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Abstract 
Severe burn injuries lead to significant morbidity and mortality as they are traumatic and 
affect nearly every organ system. Commonly used clinical practices are early burn lesion 
removal and skin grafting which have improved outcomes for patients with severe burns by 
lessening mortality rate and length of hospitalisation (Wood 2014). However, the challenges 
of sourcing donor site tissue especially as in the case of large burn wounds, and poor healing 
outcomes, for example, scarring, still remain.  
Tissue engineering combines science and engineering to create functional tissue and organs 
to maintain, restore or replace diseased parts of the body (Peltola et al. 2008). The 
applications of tissue engineering are broad; from aiding the growth of new skin, to the 
delivery of biologically active molecules such as stem cells and growth factors in order to 
enhance wound healing and regeneration of skin tissue (Kang et al. 2018). The fundamental 
goal of dermal tissue engineering is to create new fully functional skin including all skin 
appendages such as blood vessels, nerves, and sweat glands (Wang et al. 2018). This tool not 
only aids in healing and regeneration, but also to reduce scarring and the long-term 
consequences associated with having scarred tissue (Chua et al. 2016).  
The electrospinning technology is a popular choice when it comes to producing nanofibers 
with large surface area to volume ratios and structural architecture similar to the extracellular 
matrix (ECM) found in skin tissue. Chitosan is the second most abundant natural biomaterial 
after cellulose (Schiffman and Schauer 2007) and possesses enticing advantages for use in 
tissue engineering are due to: its intrinsic biocompatibility, biodegradability and high-water 
adsorption capability.  
Chitosan based composite nanofibers, blended with carrier polymers polyvinyl alcohol 
(PVA) and polyvinyl pyyrolidone (PVP) were prepared by the electrospinning method. The 
blend solutions were characterised before electrospinning using rheology. The synthesised 
three-dimensional electrospun nanofibrous scaffolds (3DENS) were characterised by SEM, 
FTIR, degradation, and swelling studies. The biological compatibly of the 3DENS were 
characterised by MTT and live-dead cell assay using cultured human keratinocytes (HaCaT) 
and normal human dermal fibroblasts (NHDF) cells lines.  
The dry weight ratio of materials influences the viscosity and spinnability of the material. 
3DENS were successfully fabricated using chitosan, PVA and PVP. The 3DENS mechanical 
vii 
   
and chemical properties were affected by the varying concentrations of materials. 
Crosslinking the 3DENS using heat increased the water adsorption capability by increasing 
the number of functional hydrophilic groups in the 3DENS. Crosslinked 3DENS resisted 
degradation compared to uncrosslinked 3DENS. The addition of chitosan to PVA/PVP 
increased the rate of degradation for uncrosslinked and crosslinked scaffolds. All the 
fabricated 3DENS displayed excellent biocompatibility. Uncrosslinked 3DENS showed 
better NHDF cell viability than crosslinked 3DENS. However, all 3DENS provided a 
favourable environment for cell viability and growth for HaCaT and NHDF cells.   
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1.0 Literature Review 
1.1 Introduction 
The World Health Organisation (WHO) reported that burn injuries are the direct cause of 
over 265 000 deaths per year with most of these cases occurring in the low- to middle-income 
countries (WHO 2019). In New Zealand, burn injuries are the seventh leading cause of non-
fatal injuries in children age 0 to 14 years (Aotearoa 2015).   In Australia, severe burn or 
scald injuries are responsible for approximately 10,000 hospitalisations each year (Wang et 
al. 2018).  
The financial burden worldwide warrants for novel strategies to achieve effective wound 
healing (Boateng and Catanzano 2015). While a combination of established prevention 
strategies and developments in the care of burn patients have made a considerable impact in 
reducing the rate of burn related deaths, these efforts have not been completely translated to 
low- and middle-income countries. Doing so would significantly reduce the global rates of 
burn-related death and disability. With this in mind, solution strategies should consider cost-
effectiveness, ease of fabrication, use of readily obtainable material and the environmental 
impact.  
In order to design an effective treatment option, it is important to understand the structure and 
function of the skin and burn wound pathology. The present thesis is organised as follows: 
firstly, there will be a review of literature which discusses the function and architecture of the 
skin, pathology of dermal burn wounds, outline the current treatments available and their 
limitations, and finally provide an overview of tissue engineering as a solution.  
1.1 The Skin: Structure and Function 
The skin is not only the largest but also the most active immune organ in our body (Salmon, 
Armstrong, and Ansel 1994). It is vital in thermoregulation, maintaining body fluid 
homeostasis, regulating many metabolic processes and serving as the first line of defence 
from external environments. In general, three distinct layers make up the skin; the epidermis, 
dermis and hypodermis (Figure 1).  
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Figure 1. Structure of the skin 
The figure shows the structure of skin (a), and layers of skin including epidermis, dermis, and 




   
The epidermis, which is the top layer of the skin, is formed primarily of keratinocytes (95%) 
and provides a barrier from exogenous chemicals, pathogens and substances, and also 
regulates fluid in order to prevent dehydration (Chua et al. 2016). The epidermis is attached 
to the underlying dermis layer by a specialised basement membrane zone consisting of 
different types of collagen fibre. Next is the dermis which is the layer between the epidermis 
and hypodermis, composed of a thicker layer of connective tissue consisting mainly of the 
extracellular matrix (ECM). ECM is the structural component of skin which provides 
mechanical strength and elasticity. Spread throughout the ECM are cells such as fibroblast, 
endothelial cells, smooth muscle cells, and mast cells (Chua et al. 2016). 
Glycosaminoglycans (GAGs) are a key organic constituent of the ECM (Salbach et al. 2012). 
The two main types of GAGs are non-sulphated GAGs such as hyaluronic acid, and, 
sulphated GAGs, such as chondroitin sulphate (Gandhi and Mancera 2008). Various types of 
GAGs make up 0.1% - 0.3% weight of the epidermis and dermis of skin tissue (Bernstein et 
al. 1996). Despite their small amount, they have a large water retaining capability and thus 
define skin volume and elasticity (Bernstein et al. 1996).  
Also present in this layer is collagen protein, hair roots, sweat glands, blood vessels, 
lymphatic vessels, nerve cells, and mesenchymal stem cells (MSC) (Gurtner et al. 2008). The 
inner most layer, the hypodermis or subcutaneous fat, functions to support and anchor the 
dermal and epidermal layer and is comprised of vasculature, fibroblasts, adipocytes, 
macrophages and nerves, (Bellas et al. 2012). The epidermis and dermis communicate in 
order to maintain homeostasis via distinct glycoprotein and proteoglycans in the ECM 
structure of the epidermis and protein in the basement membrane of the epidermis.  
1.2 Dermal wounds 
Since the skin is the outer most part of the body, it is the most exposed to external factors 
making it prone to damage. Types of trauma to the skin includes surgery, injury, abrasions, 
and burns. A dermal wound can be described as a disruption to the anatomical structure and 
function of the skin. It can extend to deeper structures like the hypodermis, muscles, tendons, 
vessels, nerves, and even bone (Boateng and Catanzano 2015).  
Dermal wounds can be characterised according to the number of layers that are affected as 
follows: 1) superficial wound where only the dermal layer is affected, 2) partial thickness 
wound where both epidermis and dermis layers are affected including appendages such as 
blood vessels, hair follicles and sweat glands, 3) full thickness wound where subcutaneous 
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fat/deeper tissues are damaged in addition to the epidermis and dermis (Boateng and 
Catanzano 2015).  
Based on their repair process, wounds can be further classified as either acute or chronic. The 
first type usually heals completely within 8-12 weeks with minimal scarring (Percival 2002). 
They are primarily caused by external factors for example, knife, gunshots, and surgical 
incisions. Chronic wounds such as burns are in a prolonged state of inflammation (Salbach et 
al. 2012). Here, persistent release of proteases including matrix metalloproteinases (MMPS) 
and reactive oxygen species (ROS), damage surrounding tissue (Salbach et al. 2012). This is 
not ideal as the ECM, growth factors and their receptors are needed for the healing process.  
In the event of a wound, the normal physiological conditions are disrupted. Slow and 
incorrect repair can cause things such as loss of skin, hair, onset of infection or skin disease, 
injury to the circulatory system and in severe cases, necrosis of the tissue (Boateng and 
Catanzano 2015). Several inter-related biological activities at molecular level are involved 
for wound healing. In general, wound healing occurs in five highly integrated and 
overlapping physiological phases: inflammation, cell recruitment, matrix deposition, 
epithelialization and tissue remodelling (Wang et al. 2018).  
1.3 Burns 
Usually two criteria are used to classify the severity of burns (Jahromi et al. 2018). In the first 
method, the depth of the thermal damage is assessed and further categorised into four 
degrees. In the first degree, the burn wound comprises of only the epidermis. The site of 
damage exhibitions redness, dryness and pain. Second degree burns can affect the upper or 
deeper dermis and usually presents with blistering of the skin, with a yellow or white colour 
and moist appearance. Third degree burns involve full thickness damage to both the 
epidermis and dermis. It has a stiff or leathery consistency and scarring, and contractures will 
form after healing.  In fourth degree burns, fatal damage is cause in the underlying tissues, 
tendons, ligaments, muscles and even bone (Jahromi et al. 2018). 
In the second method, the percentage of total body surface area (TBSA) affected by the 
injury is estimated. When burns are assessed in terms of percentage of TBSA, a precise 
assessment can be evaluated by the criteria set by Lund Browder charts where a range of 
proportions of body parts in adults and children are accounted for e.g. burn wound >10% in 
children have the same severity as 15% for adults. Hypovolemic shock can be potentially life 
threating and is therefore an important measure. Loss of fluid from damaged micro vessels 
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produces oedema and hypoproteinaemia in burns where about 25% of the body is affected 
(Jahromi et al. 2018). 
1.3.1 Burn Wound Healing 
1.3.1.1 Homeostasis Phase 
This initial phase occurs approximately 10 minutes after the thermal insult has occurred. The 
autonomic response tries to keep the damage to a minimum. During this phase, several events 
occur including platelet aggregations, immune activation, blood clotting and complement 
system activation. The blood clot is composed of vitronectin, fibrin, fibronectin and 
thrombospondins, which provides a scaffold-like matrix for the migration of keratinocytes, 
fibroblasts, leukocytes and endothelial cells along with causing an accumulation of growth 
factors (Gurtner et al. 2008).  
1.3.1.2 Inflammatory Phase 
This phase occurs 1-3 days after infliction of the wound. In the early phase neutrophils arrive 
and produce factors that start the inflammatory response and trigger other factors including 
vascular endothelial growth factor (VEGF) to repair blood vessels. In the late phase, 
monocytes transform into macrophages that produce more growth factors including fibroblast 
growth factor (FGF), platelet-derived growth factor (PDGF) and VEGF, in order to 
encourage cell expansion and migration, and generation of ECM by native skin cells. After 
about four days, adaptive immunity takes place which mainly involves lymphocytes (Li, 
Chen, and Kirsner 2007, Strbo, Yin, and Stojadinovic 2014). 
1.3.1.3 Proliferation Phase  
The proliferation phase includes three steps and occurs 3-10 days after injury. In the first 
phase, cytokines and growth factors cause increase in epithelial cells, keratinocytes, 
fibroblasts and stem cells causing reepithelialisation. Some fibroblast cells differentiate into 
myofibroblasts that construct ECM which offers a suitable structure for cell adhesion and 
organises the growth and differentiation of the cells including fibroblasts. The second step in 
the proliferation phase is new blood vessel formation (angiogenesis). The production of 
granulation tissue makes up the final stages of this phase. Fibroblasts are the key cells driving 
the granulation phase as they produce collagen and other ECM molecules. In the end, 
fibroblasts differentiate into myofibroblasts, forming a scar, or undergo apoptosis. In 
particular, the collagen that is responsible for producing a mature scar (Jahromi et al. 2018). 
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1.3.1.4 Remodelling Phase 
This is the final step of wound healing process and initiates 2-3 weeks after the burn has 
occurred and continues for as long as a year or more. More collagen and elastin are produced 
by the wound scar and the fibroblasts mature into myofibroblasts. Apoptosis of keratinocytes 
and inflammatory cells, like T cells and macrophages, also plays an important role in ending 
the response to injury (Jahromi et al. 2018).  
1.3.2 Overview of Current Treatments for Burn Injuries 
In cases of burns that are partial or full thickness wounds, the primary healing process or 
suturing are not enough to close the wound and surgical procedures are required. This is due 
to the prolonged inflammation occurring which ultimately leads to destruction of the 
surrounding tissue including ECM, growth factors and receptors needed for the healing 
process (Salbach et al. 2012).  
Autologous skin grafting remains to be the gold standard treatment for full and partial 
thickness burns. Skin grafting involves taking a piece of skin from an unburnt part of the 
body and grafting it onto the wound. In practice, donor site is limited when the burn is 
extremely large (>50% total body surface area) (Wang et al. 2018). Repeated harvesting of 
donor tissue can address this however, pain, slow healing of donor site, scarring and possible 
discoloration of the skin can be a problem (Wang et al. 2018). Meshing the donor tissue 
increases the graft site by up to four times and is a technique used in clinical practice. While 
this practice reduces the need for the amount of harvesting required, it also reduces the 
quality of the original tissue and results in the patient skin healing with mesh patterns and 
severe scarring (Wang et al. 2018).   
Several acellular and cellular skin substitutes exist on the market as an alternative to skin 
grafting. Acellular substitutes may contain combinations of natural and synthetic polymers, 
and organic molecules like proteins and fats but do not contain any living material. On the 
other hand, cellular substitutes, as the name suggests, contain living cells or are from living 
origin. Cellular skin substitutes can be distinguished by their origin: autologous (from the 
patient themselves), syngeneic grafts (from genetically identical individual e.g. monozygotic 
twin), allogenic (another human individual) or xenogeneic (from a different species) 
(Barbosa et al. 2016). The limitation of the use of allogenic grafts includes the availability of 
skin banks, safety for patient, denial of use based on religious beliefs, and the risk of viral 
disease transition (Shevchenko, James, and James 2009). The transfer of porcine retrovirus 
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and prion diseases are a major concern when it comes to grafts engineering from xenogeneic 
origins (Barbosa et al. 2016). Skin substitutes available on the market for the treatment of 
burn injuries and their constituents are listed in Table 1. 
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Table 1. Existing skin substitutes for the treatment of burns 
Skin Substitute Composition Reference 
Acellular 
Integra ® Bovine collagen, GAG, silicone  
(Dantzer and 
Braye 2001) 
Renoskin Bovine collagen 1, GAG 
(Fabienne et al. 
2007) 





bovine type I, II and V collagen covered 
with bovine elastin hydrolysate 








Porcine small intestine submucosa 






trimethylencarbonate and ε‐caprolactone 









   
Biobrane® 
Silicone bonded to woven nylon 
containing peptides from type 1 porcine 
collagen 
(Farroha et al. 
2013) 










Permacol™ Acellular porcine-derived matrix 
(MacLeod et al. 
2008) 
GlyaDerm® 
Derived from glycerol-preserved human 
allogeneic skin, containing collagen and 
elastin 









atelocollagen type I derived from 













   





Membrane incorporating hyaluronic 
acid, autologous keratinocytes and 
fibroblasts 
(Lam et al. 
1999) 






Nylon mesh coated with collagen, 






Bilayered substitute of bovine type 1 
collagen matrix with fibroblast, and 
epidermal sheet derived from 
keratinocytes 
(Barbosa et al. 
2016) 
Epicel® 
Epidermal autograft made of autologous 
keratinocytes grown in vitro in the 
















Dermis and fully stratified epidermis 
generated from Neonatal Immortalized 
KeratinocyteS (NIKS) 
(Schurr et al. 
2009) 
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OrCel® 
Bilayered type 1 collagen matrix, 
keratinocyte, fibroblasts 
(Still et al. 
2003) 
MySkin™ 








   
Mortality following a burn injury is most commonly due to wound infection (Wang et al. 
2018). Worldwide, most infections are caused by gram negative bacteria: Pseudomonas 
aeruginosa, Klebsiella pneumonia and Escherichia coli (Azzopardi et al. 2014, Issler-Fisher 
et al. 2016).  The presence of gram-negative bacteria and the gram-positive Staphylococcus 
aureus independently predict mortality (D'Avignon et al. 2010). Some antimicrobial agents 
such as silver sulfadiazine, have been reported to show poor healing outcomes with little 
evidence of preventing wound infections compared to alternate dressings (Aziz, Abu, and 
Chong 2012). This prompts investigation into alternate antimicrobial agents that do not 
compromise wound healing. The role that naturally antibacterial biomaterials can play to help 
address this problem is discussed later in this review. 
1.4 Tissue Engineering – Dermal 
Tissue engineered dermal substitutes provide a suitable alternative to harvesting and using 
skin grafts, thereby eliminating the need to create a wound elsewhere in the body in order to 
obtain healthy tissue. Moreover, harvesting skin tissue to be used as a graft is a painful 
process that results in further scar tissue. The engineered scaffold should take into account 
the patient’s safety, clinical efficacy and ease of use and the materials used should be 
practical so that it may achieve clinical acceptance (MacNeil 2007). 
Tissue engineering is an approach in regenerative medicine that focusses on the regeneration 
and restoration of functional cells, tissue, and organs (Dieckmann et al. 2010). In this 
approach, a three-dimensional (3D) material is created and referred to as a matrix or scaffold 
that is gelatinous or porous in nature. As in the case of severe burns where native tissue is 
destroyed, the scaffold provides guidance and mechanical support for the growth of fully 
functional skin including all skin appendages (Yeong et al. 2004). The 3D nature of the 
scaffold should encourage the migration, proliferation, and differentiation of incorporated 
cells within the structure and not only on the surface (Landers et al. 2002).  
The ideal tissue engineered substitute should protect the injury from protein loss, inhibit 
exogenous microorganism invasion, mimic the natural skin functions and improve the 
aesthetic appearance of the wound site (Wu et al. 2016). It should adhere to the wound bed, 
allow vascularisation and must not illicit an immune response from the body in order to 
effectively heal the wound (MacNeil 2007). In order for new tissue to form, the originally 
implanted scaffold matrix needs to be broken down and cleared therefore, materials used to 
fabricate the scaffold must be entirely biodegradable with nontoxic by-products. The scaffold 
13 
   
material should eventually degrade within the body and leave behind a matrix of connective 
tissue that resembles structural and mechanical properties of the native skin.  
It is a well-known fact that nanostructures are the most ideal choice for the fabrication of 
tissue regeneration scaffolds due to their large surface area and small pore size. Nanofibrous 
scaffolds have shown positive outcomes in enhancing cell attachment, stimulating cell 
proliferation, protein adsorption and assisting in cell differentiation (Tysseling-Mattiace et al. 
2008, Woo, Chen, and Ma 2003).  
Over 30 new skin substitutes have been tested or used in the treatment of burn injuries since 
2000 (Table 1) and these can be categorised into biological substitutes, synthetic substitutes 
or a combination of both. Various biomaterials and fabrications techniques have been used 
over the years to engineer tissue scaffolds. Fabrication methods for scaffolds include 
techniques such as solvent casting and particulate leaching, phase separation, solution 
casting, freeze-drying, melt moulding and gas foaming. The above listed methods are not 
precise at controlling pore architecture; such as size, geometry, interconnectivity, and spatial 
distribution (Peltola et al. 2008).  Moreover, many of these techniques utilise organic solvents 
to dissolve synthetic polymers which leaves behind residues that are toxic and carcinogenic 
to cells (Peltola et al. 2008). 
Advanced methods of scaffold fabrication that attracts a lot of attention nowadays include 
rapid prototyping (RP), hydrogels and electrospinning. RP techniques uses computer-aided 
design (CAD) data to print a series of cross-sectional layers using bio-inks and polymer 
solutions. However, based on the results of our literature search, very few RP techniques are 
suitable for fabricating soft tissue such as skin. Busaina et al. used stereolithography to entrap 
cells in a PEO hydrogel scaffold (Dhariwala, Hunt, and Boland 2004). The resulting hydrogel 
had desired shape but did not have pore structure or display high mechanical properties 
which can be attributed to the use of PEO alone. Another limitation of the study was the use 
of photo initiator which is toxic to cells (Dhariwala, Hunt, and Boland 2004) 
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1.5 Electrospinning Nanofibrous Scaffold: Theory and Set Up 
The electrospinning method relies on the stretching of a charged polymer solution jet 
(Haider, Haider et al. 2018). It is dependent on the coulomb forces between surface charges 
of the fluid and the applied force of the external electric field. The electrospinning set up 
consists of four main parts: (1) a syringe containing the polymer solution that is to be 
electrospun, (2) a metallic needle and (3) a metallic collector (which can be of varying 
morphology), and (4) a power supply. The polymer solution is fed through the needle at a 
constant flow rate. The needle is connected to a power supply and the induced charge moves 
into the polymer solution via the needle causing instability within the polymer droplet 
(Haider, Haider, and Kang 2018). On the other end, the collector is oppositely charged 
creating an electric potential that opposes the surface tension of the polymer solution droplet. 
The electric potential created between the needle and collector causes the polymer solution to 
be drawn in the direction of the electric field (towards the collector) (Haider, Haider, and 
Kang 2018). Increasing the electric field will result in a Taylor cone being formed; this is 
conical shaped, from which nanofibers emerge and get collected on the collector plate at an 
optimised distance (Haider, Haider, and Kang 2018). The nanofibers are formed as a result of 
the whipping motion that occurs due to the electric field in the chamber, allowing the 
polymer chains within the solution to stretch and slide past each other (Bae et al. 2013, 
Haider et al. 2013). In order for a stable jet to form, the solution must have sufficient 
cohesive force (Haider, Haider, and Kang 2018).  
Electrospun mats have been utilised for several different biomedical applications including 
pharmaceutical repositories, drug-loaded carriers for medical therapy, nucleic acid delivery 
for gene therapy, tissue engineering, filtration material, among others (Ding et al. 2019). 
They mimic diversified hierarchical structures found in the natural ECM with regard to 
structure and composition depending on the materials chosen (Mahoney et al. 2012). The 
simple technology allows the fabrication of ultra-fine solid and continuous fibres of polymers 
with diameters ranging from 1-1000 nm (Subramanian et al. 2014). Moreover, is a relatively 
cost-effective and easy technique. Its ability to spin versatile materials, both natural and 
synthetic polymers, is a major advantage.  
Interconnected pores in electrospun scaffolds allow for new vessels to grow. Moreover, it can 
play a role in directing the growth by the size of the porous channel. The small pore size 
means the polymeric nanofibers have a large surface area allowing more sites for cell 
adhesion and proliferation. However, too small pores can pose the limitation of reduced cell 
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infiltration to deeper layers of the scaffold. Therefore, pore size should be adequate to allow a 
3D infiltration within the scaffold rather than two dimensional (2D), where cells only 
populate the surface of the scaffold (Haider, Haider, and Kang 2018). 
A number of factors affect the electrospinning process which can be classified as 
electrospinning, solution, or environmental parameters. The effects of each are explained 
below and summarised in Table 2.   
1.5.1 Electrospinning Parameters 
Electrospinning parameters include the voltage applied in the chamber, the distance between 
the tip of the needle and the collector, the rate at which the solution is delivered in the 
chamber (flow rate), and the collector type. The minimum voltage required to deform the 
spherical droplet into a Taylor cone and form nanofibers is the critical voltage (Laudenslager 
and Sigmund 2012). The critical voltage varies between different polymers and combinations 
of polymers, as does the flow rate. Critical flow rate for a polymeric solution ensures the 
formation of uniform beadless nanofibers. Using flow rates beyond critical value leads to 
increase in fibre diameter and pore size due to incomplete drying of the polymer solution 
between the needle tip and collector, and therefore less stretching (Megelski et al. 2002). The 
non-evaporation of the solvent and low stretching can result in ribbon-like structures (Li and 
Wang 2013). Because flow rate affects fibre formation and size, the minimum flow rate 
required to maintain a balance between the leaving polymeric solution and the replacement of 
that solution at the tip of the needle during jet formation, thereby producing a stable jet is 
preferred (Megelski et al. 2002). A receded jet can also form where no obvious droplet or 
cone is formed at the tip of the needle and the polymer jet arises from inside the needle 
(Haider, Haider, and Kang 2018).  This type of jet produces scaffold with a range of fibre 
diameters because is not a stable jet, due to the receded jet frequently being replaced by a 
cone jet (Haider, Haider, and Kang 2018).  
Surface charge density is another important factor that affects the morphology of the 
nanofiber. Flow rate and electric current have been found to be directly related (Theron, 
Zussman, and Yarin 2004). In his study of PEO, Theron et al., observed a decrease in surface 
charge density with an increase in flow rate and a simultaneous increase in the electric 
current (2004). The needle to collector distance also affects the morphology as it relies on the 
deposition time, evaporation rate of solvent and the period of whipping motion (Matabola 
and Moutloali 2013).   
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Table 2. Parameters that influence fibre morphology in the electrospinning setup 
Parameters Effects on Fibre Morphology References 
Electrospinning Parameters 
 Increase Decrease  
Applied voltage 
Decrease in fibre diameter attributed to the 
stretching of polymer solution associated with 
the charge repulsion within polymer jet, an 
increase beyond the critical voltage will result 
in the formation of beads.  
Increase in fibre diameter 
 
(Sill and von Recum 2008, 
Topuz and Uyar 2017) 
Distance between tip 
and collector1 
Formation of beads with too large distance, 
minimum distance required for uniform fibres 
Formation of beads with too small 
distance, minimum distance 
required for uniform fibres 
(Ki et al. 2005) 
Flow rate 
Increase in fibre diameter and pore size 
generation of bead with too high flow rate, 
possible formation of ribbon-like structures. 
Decrease in fibre diameter, 
(Haider, Haider, and Kang 
2018, Megelski et al. 2002, 
Nadri, Nasehi, and Barati 
2017) 
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Collector type 
Influence structural morphology of electrospun fibres. A non-conductive collector 
creates a porous structure with circular pores on the fibre surface 
(Sill and von Recum 2008) 
Solution Parameters 
 Increase Decrease  
Viscosity 
Increased fibre diameter and disappearance of 
beads 
Bead generation (Ramakrishna et al. 2006) 
Polymer concentration Increase in fibre diameter  Decrease in fibre diameter (Megelski et al. 2002) 
Molecular weight of 
polymer 
Reduction in the number of bead and droplets  
Increase in the number of bead and 
droplets 
(Malik et al. 2015) 
Conductivity 
Decrease in fibre diameter, if conductivity is 
too high results in negative effect on Taylor 
cone 
Increase in fibre diameter, if 
conductivity is too low, Taylor 
cone cannot form 
(Haider, Haider, and Kang 
2018, Lee et al. 2015) 
Surface tension 
High surface tension results in instability of 
jets, no conclusive link with fibre morphology 
No conclusive link with fibre 
morphology 
(Khalil et al. 2015) 
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Environmental parameters 
 Increase Decrease  
Humidity 
High humidity results in circular pores on the 
fibres 
- 
(Bedane et al. 2016, Park and 
Lee 2010, Pelipenko et al. 
2013) 
Temperature Decrease in fibre diameter Increase in fibre diameter (Liu et al. 2016) 
1cases where no effect was seen (Zhang et al. 2005).  
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1.5.2 Solution Parameters 
The solution parameters include viscosity, polymer concentration, molecular weight of the 
polymer, conductivity of the solution, and surface tension. The solvent used to make the 
solution should completely dissolve the polymer. Generally, higher volatile solvents are 
preferred as they have lower boiling points and thus high evaporation rates which 
encourages solvent evaporation from the nanofiber during flight from the needle to the 
collector (Haider, Haider, and Kang 2018). However, they can also dry too quickly and 
cause drying and subsequent blocking of the needle. Comparably, less volatile substances 
may prevent solvent evaporation during flight time due to low boiling points (Haider, 
Haider, and Kang 2018).  The use of two solvents, one solvent and one non-solvent, with 
different evaporation rates will lead to phase separation and result in a highly porous 
scaffold (Sill and von Recum 2008).  
Since electrospinning relies on the stretching of charged jet, it is also affected by polymer 
concentration. In instances where the polymer concentrations in the solution are low, the 
entangle polymer chains to break in the electric field before they reach the collector (Haider 
et al. 2013, Pillay et al. 2013). The fragments then lead to the formation of beads. By 
increasing the polymer concentration in the solutions, and thereby increasing its viscosity, 
we can increase the number of chain entanglements and overcome the surface tension; 
resulting in bead-free, uniform fibres (Haider, Haider, and Kang 2018).  
On the other hand, increasing polymer concentration beyond the concentration at which 
uniform fibres can be obtained, leads to defective nanofibers as the flow of solution is 
hindered due to drying of the solution at the tip of the needle (Haider et al. 2013).  Doshi et 
al. reported that the optimum viscosity for the generation of electrospun fibres is 800-
4000cp.  
A conductive solution has enough free charges to move onto the surface of the solution 
droplet (electrostatic force of surface charges) and form a Taylor cone in the presence of the 
external applied electric field (Haider, Haider, and Kang 2018). Without conductivity or 
with lower conductivity, the droplet will not have sufficient surface charge to form a Taylor 
cone. Not only does the solution conductivity affect formation of the Taylor cone, but it 
also controls the diameter of the nanofiber (Haider, Haider, and Kang 2018). The addition 
of salts to increase polymer solution conductivity is a common practice as it increases the 
number of ions in the solution, thereby increasing the surface charge on the droplet, and 




1.5.3 Environmental Parameters 
Environmental parameters include humidity and temperature. Humidity can affect the 
solidification process of the charged jet and change fibre morphology. Studies have shown 
that in general, fibre diameter decreases with an increase in humidity (Park and Lee 2010, 
Pelipenko et al. 2013). Binary solvent systems are also affected by humidity as they rely on 
different evaporation rates of the two solvents; a technique which can be used to create 
porous nanofibers (Bae et al. 2013). Increasing temperatures lead to an increase in the 
evaporation rate of the solvent and a decrease in the solution viscosity. Both of which result 
in smaller fibre diameter (Haider, Haider, and Kang 2018). Environmental parameters may 
be an important consideration when fabricating electrospun scaffolds on a large scale in 
tropical countries.   
1.6 Biomaterials for Skin Tissue Engineering 
Biomaterials can be distinguished by their ability to degrade or be incorporated in by 
biological host (Banyard et al. 2015). They are often used for creating the structure of skin 
substitutes and should be evaluated to determine the presence of any toxic effects to the 
body, taking into account the inflammation, wound healing and immunological responses 
they elicit (Anderson 2019, Dieckmann et al. 2010). They can be of synthetic or natural 
origin and are acellular.  
1.6.1 Synthetic Polymers in Dermal Tissue Engineering 
Most synthetic polymers are degraded via chemical hydrolysis and insensitive to enzymatic 
processes so that their degradation does not vary from patient to patient (Yang 2001). Poly 
(ethylene oxide) (PEO) is one of the few polymers approved for internal use in cosmetics, 
food and pharmaceuticals. It is easy to process and therefore utilised for many biomedical 
applications (Mahoney et al. 2012). Poly (lactic acid) (PLA), and poly (glycolic acid) 
(PGA), are thermoplastic polymers characterized by polyesters links of, respectively, lactic 
or glycolic acid have an extensive U.S. Food and Drug Administration (FDA) approval 
history. They are both biodegradable and can be absorbed in vivo. They have been applied 
in the fabrication of absorbable suture material and wound healing grafts (Chong et al. 
2007, Lou et al. 2008). However, it should be pointed out that all polyesters release acidic 
degradation products that can adversely affect biocompatibility (Yang 2001). The concern 
is regarding toxic residual monomers from incomplete polymerisation as well as 
degradation products and plasticisers and therefore, require extensive and comprehensive 
testing prior to clinical translation. Moreover, these polyesters tend to be relatively stiff 
materials. While this may be an advantage in load-bearing applications, it becomes a 
disadvantage when mechanical compliance for soft tissue application (Yang 2001).  
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Polyvinyl alcohol (PVA) is the largest volume synthetic resin produced in the world. It is 
hydrophilic in nature and displays bioadhesive properties. It is biocompatible and degrades 
into water and carbon dioxide and hence has been widely used for a variety of biomedical 
applications owing to its non-toxic and non-carcinogenic nature (Subramanian et al. 2014). 
PVA has become a popular synthetic blending polymer for use with natural polymers to 
facilitate their electrospinning due to its superior rheological and fibre forming properties 
(Jia et al. 2007).  
Polyvinylpyrrolidone (PVP) is a water-soluble polymer that is chemically inert and 
biocompatible. It is a viscosity enhancer, lubricator and an important precursor polymer 
(Gökmeşe, Uslu, and Aytimur 2013). Subramanian et el, created and evaluated a PVA and 
PVP scaffold using the electrospinning technique and for tissue engineering and cell culture 
application and found good spreading and adhesion of NIG3T3 fibroblast cells cultured on 
the membrane. They suggest that the PVA/PVP membrane may spatially mediate cellular 
responses to promote cell attachment and proliferation (Subramanian et al. 2014). Synthetic 
polymers offer excellent mechanical properties, but they lack cell-recognition signals which 
is a major limitation of synthetic materials (Barbosa et al. 2016).  
1.6.2 Natural Polymers in Dermal Tissue Engineering 
Natural polymers and synthetic polymers have both been widely investigated for 
engineering skin tissue. Natural polymers can be obtained and isolated from a variety of 
sources including animal, seaweed or bacteria (Kang et al. 2018). Depending on their 
origin, these natural polymers can offer their own intrinsic signalling molecules for 
example, collagen and fibrin, while others such as alginate and agarose, do not (Lee and 
Mooney 2001). Both have their advantages. They display low toxicity and low chronic 
inflammatory response because of their abundance in skin and ability to be recognised by 
cell surface receptors (Barbosa et al. 2016). 
Collagen and hyaluronic acid (HA; a GAG protein), are two components in the ECM of the 
skin and have been investigated and considered ideal biomaterials for wound repair (Wang 
et al. 2018). These naturally occurring biomaterials undergo enzymatic hydrolysis (Rosso 
2005). Collagen promotes strong attachment and proliferation of keratinocytes and dermal 
fibroblasts and HA has low immunogenicity. Another essential component of human skin is 
elastin which provides structural and cell mediating functions (Wang et al. 2018). Natural 
collagen obtained from bovine or human sources poses a major risk of disease transmission. 
Eliminating or reducing the risk of disease transmission could be achieved either by using 
synthetic collagen-mimetic materials or recombinant-produced collagen (Rosso 2005).  
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Keratin is a protein-based polymer and represents the most important biopolymer in 
mammals after collagen (McKittrick et al. 2012). It has been widely utilised for various 
biomedical applications including skin tissue engineering due to its biocompatibility, 
biodegradability, bioactivity and natural abundance (Keskin, Urkmez, and Hames 2017). 
Keratin facilitates and supports fibroblast cell proliferation, promotes wound healing and 
reepithelization (Ku and Omary 2006, Wang et al. 2012). Its brittle nature and low 
molecular weight make it unsuitable for electrospinning, however, many polymers have 
been blended with keratin to facilitate the electrospinning process including PCL, PEO and 
PVA (Cruz‐Maya et al. 2019, Ma et al. 2017, Park et al. 2015).  
Other examples of natural materials are hydroxyapatites, polypeptides, hyaluronan, GAG, 
collagen, chitosan, and alginates (Barbosa et al. 2016). A widely investigated natural 
material is silk which is composed of two proteins, fibroin and sericin (Wang et al. 2018).   
Chitosan is the second most abundant polymer after cellulose, the polysaccharide is widely 
employed for many biomedical applications such as in surgical thread, drug delivery 
carriers, bone healing and wound dressing materials (Lou 2008, Nho and Park 2002, Yang 
et al. 2008). It is commercially obtained by the alkaline deacetylation of chitin. Chitin is a 
natural polymer that is easily obtained from some insects, fungi and crustacea including 
shrimp, crab and lobster sources (Ranjha and Khan 2013). The ability to obtain chitosan 
from waste products after food processing means an unconstrained, sustainable supply is 
available and one which adds value to food waste (Mahoney et al. 2012). Chitosan is one of 
few natural polymers that is antibacterial. This offers the advantage of limiting infection in 
the wound and could reduce the need of adding antibacterial drugs. The positively charged 
chitosan attaches to the negatively charged residues on the bacterial surface, damaging the 
cell membrane (Helander et al. 2001). The polycationic nature of chitosan is also 
responsible for other therapeutic properties such as fast blood coagulation and electrostatic 
immobilization of wound microorganism (Moghaddam et al. 2014, Younes and Rinaudo 
2015). Moreover, it possesses a structure that is similar to glycosaminoglycan (GAG), a 
major component of dermal ECM, making it an excellent candidate for tissue engineering 
(Mahoney et al. 2012). Gökmese and others said it could speed the synthesis of collagen in 
the early stages and accelerate tensile strength of wounds (Gökmeşe, Uslu, and Aytimur 
2013).  
Chitosan is only soluble in acidic media and some claim that this is not suitable for cell 
viability (Moghaddam et al. 2014). However, in this study, it was decided to prepare 
chitosan in a 2% acetic acid solution as used in other studies (Aytimur and Uslu 2014, 
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Gökmeşe, Uslu, and Aytimur 2013). The highly viscous nature of chitosan in an aqueous 
solution with increasing concentration makes the solution difficult to electrospin due to the 
presence of strong hydrogen bonding between -NH2 and -OH groups of chitosan (Mahoney 
et al. 2012).  Added to this, owing to its ionic nature, chitosan displays polyelectrolyte 
behaviour in solution form creating large repulsive forces between ionic groups while it is 
charged under an electric field resulting in a lack of continuous fibre formation during 
electrospinning (Mahoney et al. 2012). On the other hand, there is a risk of having 
insufficient material to produce solid fibres when using low polymer concentrations. The 
effect of parameters, such as conductivity and polymer concentration, on the formation and 
morphology of electrospun nanofiber are difficult to define for pure aqueous solution of 
chitosan (Mahoney et al. 2012).  
The biological properties of natural polymers make them of interest in research and clinical 
applications, however, their low mechanical properties, the instability of material and 
deterioration which accompanies long-term implantation limits their clinical application 
(Rosso 2005). Blending chitosan with a synthetic polymers or organic acids is an effective 
strategy to overcome some of these challenges and successfully fabricate electrospun 
chitosan containing nanofibers (Mahoney et al. 2012).  
1.6.3 Crosslinking 
Acetic acid, a commonly used solvent to dissolve chitosan, cleaves the backbone structure 
of chitosan molecules to result in mechanically weak nanofibers that degrade very quickly 
in aqueous environments such as in body fluids (Mahoney et al. 2012). A way to reduce the 
solubility and increase the structural integrity of the chitosan scaffolds is by chemical 
crosslinking. However, even a trace amount of toxic chemicals in the scaffold can alter 
cytocompatibility. A variety of crosslinkers are used to crosslink chitosan through the 
amine groups. Some of these chemicals agents include diisocyanates, N,N-disuccinimidyl 
suberate, resimene, hexamethylene 1,6-di(aminocarboxysulfonate) and epichlorohydrin 
(Schiffman and Schauer 2007).  
A popular crosslinking agent that has been highly utilised in more recent publications is 
glutaraldehyde (GA). Liu et al. used GA to crosslink porous collagen/chitosan scaffolds and 
found that the crosslinking degree is affected by the method of crosslinking used (2012). In 
general, a higher crosslinking degree resulted in scaffolds with a smoother surface and 
stronger internal structures leading to more controlled size (Liu 2012). 
Chemical modification of chitosan by GA turns chitosan hydrophilic (Beppu et al. 2007). It 
is known that wet environments are much better for wound healing and therefore this is not 
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a desirable property to have for a skin substitute for burn wound treatment. In recent work, 
chitosan membranes have been crosslinked by immersing in sulfuric acid for 24 hours 
(Shang et al. 2020). GA crosslinks chitosan by two main mechanisms. The first is by 
Michael-type adducts with terminal aldehydes and the second is via Schiff base imine 
functionality (Schiffman and Schauer 2007). The potential toxicity of GA to cells have been 
reported by Alves and others (Alves et al. 2011). 
Currently, there are two commercially available crosslinked engineered substitutes 
available in the market; GraftJacket and Integra™. GraftJacket is made from donated 
human tissue. The human tissue is treated to remove cellular components and epidermis. 
The remaining components; collagen, elastin, proteoglycans and the internal matrix of the 
dermis is chemically cross-linked to maintain the collagen architecture for cryopreservation 
(Nathoo 2014). 
Integra™ Matrix Wound Dressing (Integra Life Sciences) is a composite of crosslinked 
bovine collagen and GAG with a semipermeable silicone covering. The semipermeable 
silicone membrane functions temporarily as the epidermal layer to control water vapour 
loss and provide structural integrity. The composite matrix recruits dermal fibroblasts to the 
damaged tissue, which then makes and secretes new ECM and facilitates healing. The 
matrix was crosslinked by high temperature vacuum dehydration at 105 ºC followed by 
immersion in 0.05 wt. % GA solution (Burke 1981). The two steps also sterilised the matrix 
during manufacturing resulting in a bacteria free membrane. 
Residual GA is the main reason for cytotoxicity in scaffolds treated with GA for 
crosslinking. The use of GA means that additional treatments are needed for its removal for 
example, washing with Milli-Q water or oven drying. It is paramount that analysis, such as 
high-performance liquid chromatography, to detect residual GA must be performed 
following the removal step (Liu 2012).  
Mi and others used genipin which is a naturally occurring crosslinking reagent to crosslink 
chitosan microspheres and compared its biocompatibility to glutaraldehyde crosslinked 
chitosan microsphere in a rat model (Mi et al. 2002). They found less inflammation and 
overall a better biocompatibility when using genipin.  
A study compared three crosslinking methods to crosslink PVA/chitosan nanofibrous 
scaffolds; methanol immersion, glutaraldehyde crosslinking and heat treatment (180°C for 
3h in a vacuum oven). They found that after immersing in water, methanol treated 
nanofibrous structures were totally destroyed, glutaraldehyde crosslinked scaffolds resulted 
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in some loss of nanofibrous structures while heat treated nanofibrous structure retained its 
structure after immersion in water (Çay, Miraftab, and Perrin Akçakoca Kumbasar 2014). 
Hence, the present study utilised heat treatment crosslinking method but at a lower 
temperature for a longer period of time in attempt to reduce structural damage in 




2.0 The Current Project 
The need for an artificial material capable of successfully substituting for skin, especially in 
the case of full thickness burns, have long been recognised. This need is also present in 
diseases or injuries where large areas of the skin are damaged. Despite products like 
Integra, GraftJacket, and other commercial products that have shown favourable clinical 
outcomes (Burke 1981), skin grafting remains to be the gold standard of treatment despite 
its many disadvantages.   
It is generally well accepted that epidermal cells from the patient themselves would provide 
optimal epidermal covering. However, the use of artificially developed dermal matrixes 
offer several clinical advantages; it allows the material to be completely manufactured from 
nonviable materials in industrial batch processes and sterilized for immediate use. 
Secondly, because of it non-viable nature, they can be stored at room temperature over long 
periods of time. There is also the potential for mass production proving an opportunity for 
biological and economic use (Burke 1981). Chitosan is obtained from a renewable resource 
and add value to food waste material; while PVA and PVP are two of the most abundantly 
available synthetic polymers. 
The novelty of this work is crosslinking 3DENS made with the combination of natural 
polymer chitosan, and synthetic polymers PVA and PVP. While scaffolds of this 
combination have been fabricated before, there had been no attempts to crosslink them. 
Moreover, a crosslinking method of heat treatment only was used successfully in the 
present study making it superior to those scaffolds that used chemical means to do so. The 
temperature of 120ºC used to crosslink chitosan/PVA/PVP used in the present study has not 
been reported before.  
The combination of chitosan, PVA and PVP have previously been used to create 
electrospun constructs for wound dressing, tissue engineering and drug delivery 
applications (Aytimur and Uslu 2014, Gökmeşe, Uslu, and Aytimur 2013, Zhang et al. 
2014). Researcher electrospun chitosan in the range of 20% to 67% dry weight 
concentration, by blending them with PVA and PVP (Aytimur and Uslu 2014, Gökmeşe, 
Uslu, and Aytimur 2013, Zhang et al. 2014). They successfully fabricated nanofibers used 
several techniques to characterise blend solutions and 3DENS physically and chemically. 
These scaffolds were not crosslinked and none of these studies tested the scaffolds 
biological activity. One study used heat crosslinking to crosslink chitosan/PVA scaffold by 
heating at 180C in a vacuum oven for 3 hours and tested the scaffolds swelling ability 
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(Çay, Miraftab, and Perrin Akçakoca Kumbasar 2014), however our study is designed to 
expose the 3DENS to heat for a longer time at a lower temperature that would be less 
harmful to the surface structure. 
The present work studied solution properties, physical and mechanical properties of the 
final crosslinked and crosslinked 3DENS as well as performed in vitro studies for cell 
viability and proliferation. A diagrammatic illustration of the study design is represented in 
Figure 2. 
The aim of this work was to construct a three dimensional nanofibrous scaffold (3DENS) 
using a combination of chitosan, PVA and PVP using electrospinning as the method for 
fabrication and improve their mechanical properties using heat crosslinking method to 
thermally induce physical crosslinks in the 3DENS. It was hypothesised that the crosslinked 
scaffolds would exhibit superior physical properties compared to the uncrosslinked scaffold 
and that scaffolds containing higher percentage of chitosan would increase cell growth and 
viability. In order to achieve this aim, the objectives were set out as follows: 
1. Optimise formulation blends of chitosan, PVA and PVP in order to electrospun 
scaffolds. 
2. Characterise rheological properties of each formulation to evaluate the influence of 
changes in ratios of polymers in each formulation on electrospinning parameters. 
3. Optimise electrospinning parameters for the fabrication of scaffolds for each 
formulation blend to obtain relatively uniform fibre morphology. 
4. Physically crosslink the 3DENS using heating method. 
5. Characterise the physical and mechanical properties of the scaffolds.  
6. Evaluate the biocompatibility of the scaffold in vitro using human dermal fibroblasts 







Figure 2. Overview of the study design 
The figure illustrates the different characterisations performed (grey box) at each stage of the study 




3.0 Materials and Methods 
3.1 Materials and Blend Formulations 
Polyvinyl alcohol (PVA) and polyvinyl pyrrolidone (PVP) with an average molecular 
weight of 89 kDa and 360 kDa, respectively, were obtained from Sigma-Aldrich, USA. 
Chitosan with an average molecular weight of 890 kDa (75% deacetylation) was supplied 
by Shanghai Waseta Int’l Trading Company, China. All three polymers were used as 
received. PVA and PVP were dissolved by magnetic stirring in ultrapure water for 4 hours 
at 80°C and 90°C, respectively. Chitosan was dissolved in 2 % aqueous acetic acid solution 
at room temperature by magnetic stirring for one hour.  
Formulations were made by mixing chitosan, PVA and PVP solutions in ratios outlined in 
Table 3 by stirring for 5 minutes until a homogenous mixture was formed. Homogeneity of 
the solution was confirmed visually, that is, no separate layers were seen. 
3.2 Characterisation of Pure and Blend Polymer Solutions  
3.2.1 Conductivity and pH of Formulations 
The conductivity of the solution affects the net charge density carried by the jet in the 
electrospinning process where a higher net charge density increases the electrical force 
exerted on the jet leading to a decrease in fibre diameter (Gökmeşe, Uslu, and Aytimur 
2013). The pH and conductivity of the polymer solutions was measured using Oakton 
pH/CON 700 Benchtop Meter (Thomas Scientific, USA).  
3.3.2 Rheology  
Rheology is a branch of physics that describes the deformation and flow behaviour of all 
kinds of materials under controlled testing conditions (Mezger 2006). Rheological 
measurements were performed on an advanced rheological expansion system (ARES) 
HAAKE™ Rheostress™ 1 (ThermoFisher Scientific, USA) equipped with a Peltier unit for 
temperature regulation (ThermoFisher Scientific, Waltham, USA) and a Thermo 
HAAKETM DC30-KIO self-contained refrigerated bath with immersion circulator 
(ThermoFisher Scientific, Waltham, USA). A cone – plate geometry was used in which a 
60 mm titanium 1 cone plate (C60/T1) and a 60 mm concentric parallel bottom plate was 
used. A gap of 52 μm and a temperature of 20C was maintained throughout all tests 














F10 10% 80% 10%  
Dry weight ratio 2 87 11 9.2% 
F20 20% 70% 10%  
Dry weight ratio 5 83 12 8.4% 
F30 30% 60% 10%  
Dry weight ratio 8 79 13 7.6% 
F50 50% 40% 10%  
Dry weight ratio 17 66 17 6% 
F70 70% 20% 10%  
Dry weight ratio 32 45 23 4.4% 
Chitosan 100% - -  
Dry weight ratio 100   2% 
PVA - 100% -  
Dry weight ratio  100  10% 
PVP - - 100%  
Dry weight ratio   100 10% 
All percentages are based on dry weight of materials as a percentage of total solution. 
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3.3.2.1 Flow Behaviour  
Ideally viscous or Newtonian fluids such as water and mineral oil, have viscosities that are 
independent of shear rate and have a constant viscosity value (Mezger 2006). Shear-
thinning and shear-thickening fluids have apparent viscosities corresponding to a specific 
shear rate. A decrease in viscosity with an increase in shear rate is characteristic of shear 
thinning behaviour of fluids (e.g. polymer solutions, polymer melts), while an increase in 
viscosity with increasing shear rate is characteristic of shear thickening behaviour (e.g. 
ceramic suspensions, dental composites). The graph in Figure 3 shows the viscosity curves 
for ideally viscous, shear thinning and shear thickening flow behaviour (Mezger 2006).  
 
 
Figure 3. Typical viscosity curves 
The graph represents viscosity curves for (1) ideally viscous, (2) shear-thinning, and (3) shear-
thickening flow behaviour (Mezger 2006). 
 
Newton’s law states that shear stress,  (Pa), is the result of the product of shear rate, (s-1), 
and viscosity,  (Pas) (Mezger 2006). Therefore, viscosity can be defined by the following 
equation 1:  
 = 
        
?̇? 
Equation 1. Viscosity as a function of shear stress and shear rate 
 
The flow behaviour of formulations was studied in order to obtain viscosity functions. 
Shear rate (?̇?) was set to 0 – 200 /s over 120 seconds. A shear rate of 20 /s was applied for 





3.3.2.2 Oscillatory Amplitude Sweep 
Before performing a frequency sweep on an unknown sample, an amplitude sweep must be 
done to determine the range of frequency within which the sample behaves in a linear 
fashion. Beyond this range, the solution is permanently deformed (Tabilo-Munizaga and 
Barbosa-Cánovas 2005). This is called the linear viscoelastic range (LVR). In order to 
determine the LVR of the samples, an oscillation amplitude sweep was done for shear stress 
from 0.1 Pa to 20 Pa at frequency 0.1 Hz, 1 Hz, 10 Hz, 50 Hz, and 100 Hz at 20°C.  
3.3.2.3 Oscillatory Frequency Sweep 
The viscoelastic properties of the aqueous solutions of chitosan, PVA, PVP and blend 
formulations were followed through small-amplitude oscillatory shear experiments with 
oscillation frequency range from 0.1- 100 rad/s and strain amplitude ?̇? = 1 % (within the 
LVR) defined by preliminary amplitude sweep (Section 3.3.2.2). The storage, G’, and loss, 
G” moduli were recorded as a function of the oscillation frequency (ω).  
3.4 Optimisation of Electrospinning Parameters for Fabrication of 3DENS 
The 3DENS were fabricated using the electrospinning unit TL-BM (Tong Li Tech, 
Shenzhen, China) equipped with a metal rotating drum collector SS304, a positive high 
voltage supply device, a negative high voltage supply device, a V shaped spinneret holder 
(Tong Li Tech, Shenzhen, China), and a syringe pump. The polymer solution was supplied 
using a Luer Lock syringe, Luer Lock soft tubing and a 21 Birmingham Gauge needle 
(Figure 4). 
The working parameters in the electrospinning process were optimized to obtain uniform, 
bead free and fine fibres. To obtain smooth fibres, polymer solutions were loaded into a 
10ml syringe with a stainless-steel needle with inner diameter of 0.51 mm (21 gauge) which 
was attached to the positive electrode. A constant amount of polymer solution was supplied 
at a steady flow rate. Aluminium foil was placed over the rotating cylindrical collector 
which was attached to the negative electrode. The needle tip to collector distance was 
maintained at 15 cm. Nanofibers were obtained by electrospinning at a voltage range of 13 
kV – 23 kV at room temperature under atmospheric pressure. The formulations were tested 
to see if better fibres could be obtained by altering the voltage. Table 4 outlines the 





Table 4. Electrospinning Parameters 
The different parameters applied to each formulation in the electrospinning process. 
  
Sample ID Voltage (kV) Flow Rate (ml/h) Distance (cm) 
F10a 13 0.3 15 
F10b 15 0.3 15 
F20a 17 0.3 15 
F20b 20 0.3 15 
F30a 15 0.3 15 
F30b 18 0.3 15 
F50a 18 0.3 15 
F50b 20 0.3 15 


















Figure 4.Electrospinning unit TL-BM (Tong Li Tech, Shenzhen, China) 
The figure shows main components of the electrospinning unit (A), and side view of electrospinning 






3.5 Crosslinking  
A novel crosslinking method was utilised in the present study to thermally induce physical 
crosslinks in chitosan/PVA/PVP 3DENS by heating. The nanofibrous scaffolds were 
physically crosslinked by heating at 120C in an oven for 24 hours.  
3.6 Scanning Electron Microscopy (SEM) 
In order to determine the optimal fibre morphology, SEM micrographs were used. 3DENS 
samples were mounted on aluminium stubs using double sided carbon tape and coated with 
5 nm of gold palladium in an Emitech k575X Peltier-cooled high-resolution sputter coater 
(EM Technologies Ltd, Kent, England). They were viewed in a JEOL 6700F field emission 
scanning electron microscope (JEOL Ltd, Tokyo, Japan). Images were taken of two 
different field of views at 5000x and 15000x magnification.  
ImageJ software (NIH, USA) was used to measure the fibre diameters from the SEM 
images (Schindelin 2012). A 7 x 5 grid was placed randomly on SEM micrographs and 35 
diameter measurements were taken from each of the two field of views (n=70). The mean, 
standard deviation of the mean, minimum and maximum value are reported. A one-way 
ANOVA followed by a Tukeys Post Hoc test was performed using Graphpad Prism 8 
software (version: 8.2.0, San Diego, CA, USA). Statistical significance was set at p < 0.05.    
3.7 Fourier Transform Infrared Spectroscopy 
Chemical characterisation of 3DENS were carried out on peeled fibrous membranes and for 
raw materials of chitosan, PVA and PVP powders using an Alpha II Fourier Transform 
Infrared Spectrometer (Broker Optik, Ettlingen, Germany) equipped with RockSolidTM 
interferometer, CenterGiowTM IR-Source, a single reflection Platinum-ATR monolithic 
diamond crystal measurement interface, and a temperature stabilised DTGS detector 
(MIRacle, Pike Technologies, Madison, WI, USA) (Figure 5).  
The infrared spectra of the samples were calibrated to background spectra and measured 
over a wavelength range of 400 cm-1 to 4000 cm-1 with a resolution of 4 cm-1. The final 
spectra were a mean of 24 scans to reduce spectral noise. Data was acquired using OPUS 


















3.8 Swelling Test 
Due to the hydrophilic nature of the polymers used to fabricate the scaffold, the water 
adsorption capacity of the nanofibrous scaffolds was determined by the swelling of the 
sample (Gu et al. 2009). The swelling ability of the scaffold was measured using the 
method described by Shavandi and others (Shavandi 2015). Firstly, a circular piece of the 
scaffold with a diameter of 11 mm was cut. Weight of the scaffold with foil was taken. The 
scaffold was removed from the foil by wetting the scaffold in phosphate buffered saline 
(PBS pH 7) and then carefully removed from the foil. The initial dry weight of the scaffold 
was calculated by subtracting the weight of the scaffold and foil by the weight of the foil 
only (Wd). The scaffold was then immersed in PBS in a 15 ml falcon tube and kept in a 
37C incubator for 24 hours. Then the excess PBS was removed from the sample by 
blotting using filter paper and weighed in wet condition (Ww). Swelling ratio was calculated 
according to the following equation (2): 
Swelling (%) = 




Equation 2. Calculation of the swelling ratio 
 
Where Wd is the initial dry weight of the sample and Ww is the final wet weight of the 
sample. The experiment was replicated three times for each 3DENS sample (Gu et al. 
2009).  
3.9 Degradation  
The degradation percentage of all samples were measured at 7 and 14 days. Weight of the 
scaffold with foil was taken. The scaffold was removed from the foil by wetting the 
scaffold in phosphate buffered saline (PBS pH 7) and then carefully removed from the foil. 
The initial dry weight of the scaffold was calculated by subtracting the weight of the 
scaffold and foil by the weight of the foil only (Wi). The scaffold was then immersed in 
PBS in a 15ml falcon tube and kept in a 37C incubator for 7 and 14 days. Each 3DENS 
was removed and placed on a pre-weighed filter paper and dried in an oven at 50C for 12 
hours. The final weight (Wf) of the 3DENS was obtained by subtracting the weight of the 
filter paper from the weight of the filter paper and dried 3DENS. The degradation of the 
3DENS was defined as the amount of weight lost as a percentage of initial weight. 




Degradation (%) = 
Wi - Wf 
x 100 
Wi 
Equation 3. Calculation of the rate of degradation 
 
 
3.10 In Vitro Biological Characterisation 
3.10.1 Cell Lines 
This study utilised human adult low calcium, high temperature keratinocytes (HaCaT 
ATCC® CRL-2404), an immortalized human keratinocyte cell line, and neonatal human 
dermal fibroblasts from juvenile foreskin (NHDF ATCC® PCS-201-010). The Figure 
below shows NHDF observed using a 10X objective has a spindle shape compared to a 
cuboidal cell shape seen in HaCaT cells (Figure 6).  
 
Figure 6. HaCaT and NHDF cells viewed under a microscope 
The figure above shows A. HaCaT and B. NHDF cells under an inverted phase contrast microscope 







3.10.2 Cell Revival 
Frozen stocks of HaCaT (passage 19) and NHDF (passage 16) were removed from liquid 
nitrogen and warmed in a 37C water bath for no longer then 60 seconds. All cell culture 
work was conducted in a HeraSafe 2030i 1.2, Class II Microbiological Safety Cabinet 
(ThermoFisher Scientific, Germany) which was disinfected using 70% ethanol in dH2O 
followed by 15 minutes of UV sterilisation.  
The thawed stock solution was transferred to a sterile 75cm2 culture flask and grown to 
70%-90% confluence in sterile Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 1% Fetal Bovine Serum (FBS; Thermo Fisher, NZ) and 1% penicillin-
streptomycin (Gibco, Canada). This will be referred to as complete DMEM (cDMEM). The 
flasks were kept in a humidified incubator with 5% CO2 in atmosphere, maintained at 37C.  
cDMEM was replaced every 3-4 days.  
3.10.3 Passaging 
In order to prolong the life of the cells in culture and maintain their proliferative state, 
passaging is done by transferring some cells from the previous culture to a fresh culture 
medium. The cells were passaged when they reached 70 % - 90 % confluence by 
trypsinization to maintain their proliferative state. The procedure was carried out by first 
removing existing media via suctioning. The adhered cells were rinsed with Dulbecco’s 
PBS (DPBS; GIBCO) to remove any remaining media that can inhibit trypsin activity. 
Next, 4 ml of Trypsin (0.25 %) and ethylenediaminetetraacetic acid (EDTA) solution 
(Gibco) was added to the culture flask containing NHDF or HaCaT cells then returned to 
the incubator for 5 minutes or 15 minutes, respectively. At the end of the incubation period, 
the flasks were viewed under a binocular phase contrast microscope to confirm that the 
cells were suspended. Trypsin was inactivated by adding 8 ml of cDMEM. A further 20 ml 
of cDMEM was added to dilute the suspension. Cells were counted using Scepter™ 2.0 
Handheld Automated Cell Counter (Merk Millipore) and seeded into plates as needed. The 
remaining cells were subcultured in cDMEM.   
3.10.4 Scaffold Sterilisation  
The scaffolds were cut into 9 mm diameter by hole punching. 3DENS were immersed in 
sterile PBS for easy removal and placed on the bottom of well plates. The plates were 
exposed to UV light with the lids open in HeraSafe 2030i 1.2, Class II Microbiological 
Safety Cabinet (ThermoFisher Scientific, Germany) at KW 254 nm LW 365 nm for 30 
minutes to sterilise. Ethanol was investigated for sterilizing but was not used due to a 
visually observable change in morphology in the 3DNES when treated with ethanol. 
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3.10.5 Cell Viability Assay 
To determine cell viability within the 3DENS, cell-scaffold constructs were stained using 
the live/dead cell viability/cytotoxicity assay. Calcein blue acetoxymethyl ester powder 
(calcein blue AM, CB; CAS no.: 54375-47-2, Sigma–Aldrich, USA) and propidium iodide 
(PI, 1.5 mM stock solution in PBS; Cat no.: 421301, BioLegend, San Diego, CA, USA) 
were used for fluorescence microscopy. Sterilized 3DENS were placed at the bottom of the 
well on a cover slip. A glass cover slip without any 3DENS was used as the control. 
Cells (5 x 103 /ml) were seeded into each well containing scaffold and a control well and 
supplemented with 1 ml of cDMEM. Experiment was performed in triplicate (n=3). All 
work was done in HeraSafe 2030i 1.2, Class II Microbiological Safety Cabinet.  
 
 
Figure 7. 24-well plate layout for Live/Dead cell assay 




Cell viability of HaCaT (passage 20) and NHDF (passage 17) cells were measured 
separately at 24, 48 and 72 hours for all 3DENS. All plates were organised in the same 
manner as shown in Figure 7.  
Assay solution was prepared for each plate by pipetting 1.5µL calcein AM (Molecular 
Probes/Invitrogen #C3099) and 6 µL PI (Molecular Probes #P-3566) into 1 ml of DPBS. 
First the culture media was removed from each well and discarded. Approximately 30 µL 
of assay solution was added to the wells, ensuring the scaffold was completely covered. The 
glass cover slip with the scaffold was then removed carefully from the bottom of the well 
and placed scaffold side down onto a glass slide for viewing under BX51 microscope with a 
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fluorescent attachment (Olympus Corp., NY, USA) and images were captured using 
Olympus cellSens imaging Software (Life Science Solutions). Live cells were indicated by 
green fluorescence (excitation 528 nm, emission 617 nm) as calcein stains the intact cell 
membrane, and, dead cells were indicated by red fluorescence (excitation 528 nm, emission 
617 nm) as PI stains the cell nuclei. For quantitative analysis, cell counts were performed 
using three random field of views per 3DENS and control using 4x objective for each time 
point. The cell viability for each image was calculated according to the following equation: 
Cell Viability (%) = 
Number of Live Cells 
x 100 Total Cell Number 




3.10.6 Proliferation MTT Assay  
Methylthiazolyldiphenyl-tetrazolium bromide (MTT) was obtained from Sigma Aldrich. 
This assay can quantify the number of viable cells in a sample by relying on the conversion 
of tetrazolium salt into a formazan product by dehydrogenases present in metabolically 
active cells. The insoluble formazan has a purple colour (Figure 8) which can be solubilised 
to form a coloured solution that can then be quantified by reading the absorbance of the 
media on a spectrometer. Cell number can be calculated by reference to a standard curve. 
Cell proliferation was assessed for crosslinked and uncrosslinked samples using HaCaT 
(passage 21) and NHDF (passage 18) cell lines at 24, 48 and 72 hours. Sterile scaffolds 
were placed in the bottom of 48-well plates and organised as shown in Figure 5. The 
experiment was done in triplicate and repeated twice (n=6). All work was done in HeraSafe 
2030i 1.2, Class II Microbiological Safety Cabinet.  
Cells (5 x 103 /ml) were plated on to each well containing scaffold and a control well 
(without a scaffold and cells, i.e. media only) and supplemented with 0.5 ml of complete 
DMEM. Wells containing 80 x 103, 40 x 103, 20 x 103, 10 x 103, 5 x 103, 2.5 x 103 cells/ml 
were plated to create a standard curve. These were also supplemented with cDMEM and 
were plated in duplicate. Control wells (blanks) contained cDMEM without any cells, and 
were also plated in duplicate. The plates were organised as shown in Figure 9 for all time 
points.  
MTT (12 mM) stock solution was prepared by adding 1ml of sterile PBS to 5mg of MTT 
and vortexed until dissolved. MTT solution was wrapped with aluminium foil to protect it 
from light and kept in 4C. Stock solution of 10% sodium dodecyl sulphate (SDS) and 1M 
hydrochloric acid (HCl) in ultrapure MilliQ water was also prepared. To count the cells 
after the incubation period, assay solutions was prepared by mixing MTT solution in colour 
free media at a ratio of 1:5 (MTT solution: media). The cDMEM media was removed from 
each well and 200µL of the assay solution was added to each well and the plate was 
incubated for 4 hours. During incubation, acidified SDS was prepared by mixing 10 µL of 
HCl per 1ml of SDS and kept at room temperature. At the end of the 4-hour incubation of 
the cells in MTT containing assay solution, 100 µL of acidified SDS was added to each 
well and left in the incubator overnight. The next day, each well was mixed thoroughly and 
100 µL of solution from each well was transferred to a 96-well plate for reading in a 
spectrometer at 570 nm absorbance. Graphpad Prism 8 software (version: 8.2.0, San Diego, 





Figure 8. MTT stained live cells forming crystals 
The image shows purple staining produced by presence of formazan formed by conversion of 
tetrazolium salt into formazan by dehydrogenases present in metabolically active cells. The scale 
bar represents 200 µm. 
 
 
Figure 9. MTT assay plate set  
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3.11 Statistical Analysis 
For experiments comparing more than three groups or more, the one-way ANOVA was 
used with a Tukey post hoc analysis. For experiments comparing the two groups of 
crosslinked versus uncrosslinked, the paired or unpaired t-test was employed. A p-value of 
< 0.05 was considered as statistically significant. All conditions were done in at least 
triplicates. All results were expressed as mean  SEM. Graphpad Prism 8 software (version: 








4.0 Results  
4.1 pH and Conductivity  
The pH and conductivity values of each of the formulation solutions are listed in Table 5. 
All three polymer solutions were in the acidic pH range (pH < 7). Chitosan had the lowest 
pH at 3.88, followed by PVP at 4.58 and PVA having the highest pH at 5.86. The pH of 
blend formulations decreased from F10 to F70 (4.35, 4.25, 4.16, 4.03, and 3.96, 
respectively) 
Chitosan had the highest conductivity (3962 S/cm), followed by PVA (566 S/cm) and 
PVP had the lowest (116 S/cm).  As the percentage of chitosan increased in the blend 
formulations (F10 to F70), the conductivity of the polymer solution also increased (752 
S/cm, 938 S/cm, 1165 S/cm, 1733 S/cm, and 3926 S/cm, respectively).  
4.2 Viscosity  
The graphs in Figure 10 represent viscosity as a function of shear rate (?̇? for solutions of 
chitosan (A), PVA (B), PVP (C), F10 (D), F20 (E), F30 (F), F50 (G) and F70 (H) at 20 C. 
For all the polymer solutions, viscosity decreased as shear rate increase. This is 
characteristic of shear-thinning behaviour (figure 3).  
 Viscosity of a shear- thinning fluid is shear dependence hence, the apparent viscosity (a) 
of each sample at a shear rate (?̇?) of 200/s is reported in Table 5 in centipoise (1 mPas = 1 
cP). PVA and PVP solutions had similar viscosities ( (?̇? = 200/s) = 190 cP and 200 cP, 




Table 5. Composition and physical properties of polymer  






F10 10% 80% 10%  4.35  0.08  725  38 230 
Dry weight ratio 2 87 11 9.2%    
F20 20% 70% 10%  4.25  0.07 938  70 230 
Dry weight ratio 5 83 12 8.4%    
F30 30% 60% 10%  4.16  0.07 1165  94 220 
Dry weight ratio 8 79 13 7.6%    
F50 50% 40% 10%  4.03  0.13 1733  144 210 
Dry weight ratio 17 66 17 6%    
F70 70% 20% 10%  3.96  0.12 3962   190 200 
Dry weight ratio 32 45 23 4.4%    
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Chitosan 100% - -  3.88  0.14 3962  416 140 
Dry weight ratio 100   2%    
PVA - 100% -  5.86  0.01 566  24 190 
Dry weight ratio  100  10%    
PVP - - 100%  4.58  0.11 116 15 200  
Dry weight ratio   100 10%    
The table above outlines the components of blend formulations F10 to F70 and reports values of pH, conductivity and viscosity of all polymer solutions 





Figure 10. Viscosity curves of polymer solutions 
The graphs above represent viscosity as a function of shear rate (?̇?) for solutions of 
chitosan (A), PVA (B), PVP (C), F10 (D), F20 (E), F30 (F), F50 (G) and F70 (H) at 20 C 
(n=3).  
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4.3 Viscoelastic Properties 
4.3.1 Oscillatory Amplitude Sweep 
The results of the amplitude sweep are shown in Figure 11. The samples are not within the 
LVR at frequencies above 10 Hz. 
 
 
Figure 11. Amplitude sweep  
X and y values are in log 10 scale. 
 
4.3.2 Oscillatory Frequency Sweep 
A frequency sweep study was performed to determine G’, and G” as a function of 
frequency (ω) at a fixed temperature of 20C. The storage modulus (G’) represents the 
elastic/solid behaviour of a sample and measures the amount of deformation energy stored 
in the sample during shearing. On the other hand, the loss modulus (G”), represents the 
viscous/fluid behaviour of a sample and measures the amount of deformation energy used 
up in the sample during shearing (Mezger 2006).  G' > G'' demonstrates behaviour that is 
more elastic or solid while G'' > G' demonstrates viscous or more liquid behaviour (Tabilo-
Munizaga and Barbosa-Cánovas 2005).  
The dependence of storage G’ and loss G” modulus on the angular frequency are shown in 
Figure 12 for solutions of chitosan (A), PVA (B), PVP (C), F10 (D), F20 (E), F30 (F), F50 
(G) and F70 (H) at 20 C. For chitosan, PVP, F10, F20, F30, and F50 solutions, the stronger 
dependence of G’ on frequency and higher loss modulus (G”) indicates that the polymer 
solution is a viscous fluid with weak networks (Figure 11, A and C-H).  On the other hand, 
PVA, behaved as a structured fluid characterised by having a higher storage modulus than 




Figure 12. Graph of G’, G” plotted against omega 
The storage (G’) and loss (G”) modulus as a function of frequency (ω) is plotted for chitosan (A), PVA (B), PVP (C), F10 (D), F20 (E), F30 (F), F50 
(G), and F70 (H). The x and y axis are represented in log (10) scale. (n=3)
























































































































































4.4 Surface Morphology (SEM) 
SEM micrographs were used to evaluate the fibres produced by electrospinning at a flow 
rate of 0.3ml/hour with needle tip to collector distance maintained at 15 cm for each 
formulation at voltages ranging from 13 kV to 23 kV and are presented in Figure 13. The 
specific electrospinning parameters applied to each formulation have been outlined 
previously (Table 4). The best processing parameters are outlined in Table 6 below.  
 
Table 6. Best processing parameters 
Formulation Voltage (kV) Flow rate (ml/h) Distance (cm) 
F10 15 0.3 15 
F20 17 0.3 15 
F30 18 0.3 15 
F50 18 0.3 15 
kV= Kilovolts 
As seen from the micrograph of synthesised nanofibers, formulation F10 produced at a 
voltage of 15 kV using flow rate of 0.3 ml/h, 15 cm away from the collector (Figure 12. 
F10b) formed linear and bead free fibres.  
For F20, fibres produced using 15 kV and 17 kV look similar under SEM therefore the 
lower voltage was used to produce the final scaffold (Figure 12 F20a and F20b). F20 fibres 
are not linear and have a small amount of spindle shaped beading but thinner fibres were 
produced. F30 and F50 scaffold were also not linear and had an increasing number of beads 
with the beads getting rounder in shape, however, the fibres became thinner (Figure 12, 
F30a to F50b). A voltage of 18 kV was selected for spinning the final scaffold for 
formulation F30 and F50 as the fibres in SEM images look similar compared to the higher 
voltage tried. 
SEM image of F70a (Figure 12) showed that spraying had occurred rather than the 
production of a continuous jet, which resulted in polymer deposition as a powder rather 
than a fibre on the collector. F70 was excluded from further studies due to its inability to 



























Figure 13. SEM images x15000 magnification 
SEM Images of Formulations 1- 4 electrospun at a flow rate of 0.3 ml/h from a distance of 15 cm from the tip to the collector at varying voltages. Minimum voltage 
required to produce a polymer jet was used.  Images outlined in red represented the best observed fibre morphology and their corresponding processing parameters 
were used for fabrication of final 3DENS. 
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4.5 Fibre Diameter 
In order to calculate fibre diameter for each of the different 3DENS formulations, 35 fibre 
diameters were measured randomly from SEM images of two different field of views for 
each 3DENS at 15000x magnification using ImageJ software. The mean, standard deviation 
of the mean, and the range of the 70 measurements are reported in Table 7.   
A one-way ANOVA followed by a Tukey’s multiple comparisons test was carried out using 
prism software for all 3DENS formulation diameters (p<0.0001). Overall, the fibre 
diameter decreased from F10 to F50. A t-test was used to compare the mean of each 
3DENS fibre diameter to the others. The fibre diameter of F10 was significantly smaller 
than all other 3DENS (221 m, p < 0.0001). Fibre diameter of F20 was significantly larger 
than F50 (86 m and 53 m, respectively, p = 0.0024) but not from F30 (72 m, p=0.43). 
The difference between the diameters of F30 and F50 fibres were not found to be 
statistically significant (72 m and 53 m, respectively, p = 0.17). Out of all the 
formulations, fibre diameter distribution is comparatively very narrow for F30 (41 m- 131 
m). A wide fibre diameter distribution was observed for F10 (81 m-415 m) and for F50 
(17 m -410 m).   
 
Table 7. Fibre diameter of 3DENS 
 F10 F20 F30 F50 
Mean 221 86 72 53 
SD 78 80 18 63 
MIN 81 48 41 17 
MAX 415 228 131 410 
 334 180 90 393 





The FTIR spectra of 3DENS of chitosan, PVA, PVP, and the blend of chitosan/PVA/PVP 
for the different formulations were obtained and the results are shown in Figure 14. In the 
PVA spectrum, a weak broad transmittance at 3282cm-1 on the spectra can be assigned to 
the O-H stretching vibration of hydroxyl group of PVA (Subramanian et al. 2014). The 
peak occurring at 2938cm-1 corresponds to the C-H vibration (alkyl groups) and the band 
corresponding to CH2 asymmetric stretching (methylene group) vibration occurs at 2907cm-
1 (Subramanian et al. 2014). The bending, wagging of CH2 vibrations are at 1235cm-1 and 
1416 cm-1 (Subramanian et al. 2014). C-O stretching of acetyl groups present on the PVA 
backbone corresponds to the sharp band at 1089cm-1 (Subramanian et al. 2014). 
The infrared spectrum of PVP is characterised by strong C=O transmission peak from 
amide group of PVP at 1645 cm-1. C-N group appeared at 1227 cm-1. Peaks observed at 
1423 cm-1 and 2950 cm-1 correspond to .C-H stretching and bending vibrations 
(Subramanian et al. 2014). 
Characteristic transmittance bands for chitosan can be assigned to 1645 cm-1 corresponding 
to C=O (amide-I) stretching vibration and 1590 cm-1 corresponding to a combination of C-
N stretching and N-H bending (amide II) vibrations (Costa-Júnior, Pereira, and Mansur 
2009).  
The characteristics peaks of pure materials as listed above are present in the 3DENS of 
different formulations. The shifts in the IR peaks are characterised for each 3DENS in 
Table 8. The observed broad band around 3278 cm-1 – 3292 cm-1 in the 3DENS is attributed 
to OH stretching vibrations of PVA+PVP in the formulations. The stretching vibration of 
C=O of PVP is responsible for the strong band at 1655 cm-1 – 1658 cm-1 in the 3DENS. The 
strong band at 1082 cm-1 – 1091 cm-1 is assigned to the characteristic C-O stretching of 







Figure 14. FTIR spectra graphs of F10, F20, F30 and F50 





Table 8. The characteristic IR peaks and their assignments to varying formulations of 
3DENS 
3DENS Peak wavenumber (cm-1) Assignments 
F10 UCL 3292 
O-H stretching 
F20 CL, F30 CL, F50 UCL 3288 
F10 UCL, F30 UCL 3286 
F20 UCL 3282 
F50 UCL 3278 
F10 CL, F20 UCL, F20 CL, 
F30 CL, F50 CL 
2940 
C-H vibration 
F10 UCL, F30 UCL, F50 
UCL 
2938 
F10 UCL, F20 UCL, F30 
UCL, F50 UCL, F50 CL 
2911 
CH2 stretching 
F10 CL, F20 CL, F30 CL 2909 
F10 UCL, F10 CL, F20 UCL, 
F20 CL 
1658 
C=O stretching and N-H 
bending F30 UCL, F30 CL, F50 UCL, 
F50 CL 
1655 




F10 UCL, F30 UCL, F30 CL, 
F50 UCL 
1423 
F10 UCL, F10 CL, F20 UCL, 
F30 UCL, F50 UCL 
1237 
C-N stretching F20 CL, F30 CL 1235 
F50 CL 1231 
F10 CL, F20 CL 1091 
C-O stretching 
F10 UCL, F20 UCL, F30 
UCL, F30 CL, F50 UCL 
1089 
F50 CL 1082 
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4.7 Degradation at Day 7 and Day 14 
The degradation rate of crosslinked and uncrosslinked 3DENS were measured at day 7 and 
day 14. Figure 15 shows photographs of all samples immersed in PBS on day 7. The 
increasing delicacy of the scaffolds from F10 to F50 in both the crosslinked and 
uncrosslinked samples can be observed from the images in Figure 15; F50 CL, F30 UCL 
and F50 UCL samples appear as feathers floating in the PBS. Another important 
observation that can be made from these images are the yellow colour of the crosslinked 
scaffolds compared to the white colour of the uncrosslinked 3DENS.  
The rate of degradation of the various 3DENS as a percentage of initial weight at day 7 and 

















Figure 15. Degradation of 3DNES at day 7 in PBS at 37 C  
The figure shows images taken of uncrosslinked and crosslinked 3DENS immersed in PBS (pH 7.4) after 7 days of incubation at 37 C.
    
A) F10-CL B) F20-CL C) F30-CL D) F50-CL 
    





Figure 16. Degradation profiles of 3DENS in PBS (pH=7.4) at 37º C 
The Figure shows the percentage of weight lost after 7 days for each UCL and CL 3DENS samples 
(A), percentage of weight lost after 14 days for all UCL and CL 3DENS samples (B) and compares 




The one-way ANOVA showed that F50 UCL degraded significantly faster than F10 UCL 
(p = 0.03) at day 7 however, no significant differences were seen between CL 3DENS (p = 
0.15) (Figure 16 A). By day 14, F30 UCL and F50 UCL showed a higher degradation rate 
than F10 UCL (p = 0.01) (Figure 16 B). CL 3DENS showed no significant differences 
between formulations at day 14 (p = 0.36) (Figure 16 B).  
Figure 15 C compares degradation at day 7 and 14 for each 3DENS. A one-way ANOVA is 
not suitable for comparing two samples so T tests were done to compare degradation at day 
7 to day 14 for all UCL and CL 3DENS. The results showed that the increase in 
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degradation rate on day 14 was not significantly higher than day 7 for F10 UCL (p = 0.35), 
F20 CL (p = 0.14), F30 CL (p = 0.06), F50 UCL (p = 0.11) and F50 CL (p = 0.47). 3DENS 
degraded significantly more at day 14 compared to day 7 for formulation F10 CL (p = 
0.02), F20 UCL (p = 0.007), and F30 UCL (p = 0.004).  
4.8 Swelling 
Figure 17 shows the swelling rate of F10 UCL, F10 CL, F20 UCL, F20 CL AND F30 CL in 
PBS at 37C. It was not possible to obtain swelling data for samples F10 UCL, F10 CL, 
F20 UCL, F20 CL and F30 CL due to the samples being too delicate to handle when wet in 
order to get an accurate reading as seen in (Figure 15).  
The one-way ANOVA showed no significant differences between F10 CL, F20 CL, and 
F30 CL (p = 0.11). A one-way ANOVA is not suitable for comparing two samples therefore 
a T-test was used to compare F10 UCL and F20 UCL; no differences were found (p = 0.79). 
T-tests confirmed that crosslinked 3DENS held significantly higher adsorption compared to 



















































Figure 17. The swelling ratios of various 3DENS 
The figure above shows the swelling ratio for F10 UCL, F10 CL, F20 UCL, F20 CL and F30 CL 




4.9 Biological Analysis 
 
4.9.1 Live/Dead assay using HaCaT 
Figures 19-21 show images of 3DENS seeded with HaCaT cells at 24, 48 and 72 hours. The 
green fluorescence indicates live cells stained by calcein dye and the red fluorescence 
indicates dead cells stained by propidium iodide. The images clearly show more live cells 
then dead cells which is confirmed by the positive viability percentage shown in the graphs 
in Figures 22-24. for all 3DENS. The fluorescence images also indicated a tendency of 




Figure 18. Fluorescence images of the 3DENS seeded with HaCaT cells after undergoing 
the Live/Dead viability assay at 24 hours 
Control groups were cells seeded into wells without any 3DENS. Green indicates live cells stained 

















































































Figure 19. Fluorescence images of the 3DENS seeded with HaCaT cells after undergoing 
the Live/Dead viability assay at 48  
Control groups were cells seeded into wells without any 3DENS. Green indicates live cells stained 





























































































































































Figure 20. Fluorescence images of the 3DENS seeded with HaCaT cells after undergoing 
the Live/Dead viability assay at 72 hours 
Control groups were cells seeded into wells without any 3DENS. Green indicates live cells stained 







Figure 21. Viability of HaCaT cells on uncrosslinked 3DENS  
The graphs represent HaCaT cell viability on uncrosslinked 3DENS as a percentage at 24h (A), 48h 
(B) and 72h (C) (n=3, *p<0.05, error bars represent  SEM).   
 
HaCaT cells showed good viability (> 70 %) in all uncrosslinked 3DENS at 24, 48 and 72 
hours (Figure 22. Results of the one-way ANOVA test confirmed that F30 showed 
significantly lower cell viability at 24 hours compared to F50 and control (p = 0.01). At 48 
and 72 hours, cell viability remained above 70% however none of the 3DENS performed 





Figure 22. Viability of HaCaT cells on crosslinked 3DENS  
The graphs represent HaCaT cell viability on crosslinked 3DENS as a percentage at 24h (A), 48h 




In the crosslinked 3DENS, F20 CL showed the lowest cell viability (42 %), followed by 
F10 CL (68 %) however F30 CL and F50CL showed good viability (> 70 %) (Figure 23). 
At 48 hours, F10 CL, F20 CL and F30 CL showed good viability (> 70 %) while F50 CL 
showed the lowest HaCaT viability (58 %). By 72 hours F10 CL and F30 CL had viability 
below 70% and F20 CL and F50 CL had viability of approximately to 80 %. However, 
results of the one-way ANOVA test showed no significant differences in HaCaT cell 
viability between different CL 3DENS at 24, 48 and 72 hours (p = 0.27, p = 0.21 and p = 






Figure 23. Viability of HaCaT cells on uncrosslinked and crosslinked 3DENS  
The graphs compare HaCaT cell viability on uncrosslinked and crosslinked 3DENS at 24h (A), 48h 




A one-way ANOVA is not suitable for comparing two samples. Results of a t-test were 
used to comparing uncrosslinked to crosslinked 3DENS, uncrosslinked 3DENS F20 and 
F50 showed significantly higher cell viability than crosslinked 3DENS F20 and F50 at 24 
hours (p = 0.02 and p = 0.02, respectively) (Figure 24). The difference between 
uncrosslinked and crosslinked 3DENS for all formulations at 48 hours were not significant 
(p > 0.05). At 72 hours, uncrosslinked 3DENS showed a higher cell viability for all 




4.9.2 Live/Dead Assay using NHDF 
Figures 25-27 show fluorescence images of 3DENS seeded with and NHDF cells at 24, 48 














































































Figure 24. Fluorescence images of the 3DENS seeded with NHDF cells after undergoing 
the Live/Dead viability assay at 24 hours 
Control groups were cells seeded into wells without any 3DENS. Green indicates live cells stained 
















































































Figure 25. Fluorescence images of the 3DENS seeded with NHDF cells after undergoing 
the Live/Dead viability assay at 48 hours 
Control groups were cells seeded into wells without any 3DENS. Green indicates live cells stained 

















































































Figure 26. Fluorescence images of the 3DENS seeded with NHDF cells after undergoing 
the Live/Dead viability assay at 72 hours 
Control groups were cells seeded into wells without any 3DENS. Green indicates live cells stained 





As stated previously for fluorescence images, the green fluorescence indicates live cells 
stained by calcein dye and the red fluorescence indicates dead cells stained by propidium 
iodide. The positive viability percentage shown in the graphs in Figure 27, attest to the 
presence of more live cells then dead in the 3DENS fluorescence images. The images 
clearly show more live cells then dead cells which is confirmed by the positive viability 
percentage shown in the graphs in Figures 28-30 for all 3DENS. The fluorescence images 
also indicated a tendency of NHDF cells to infiltrate into deeper layers of the 3DENS. 
 
 
Figure 27. Viability of NHDF cells on uncrosslinked 3DENS  
The graphs represent NHDF cell viability on uncrosslinked 3DENS as a percentage at 24h (A), 48h 
(B) and 72h (C) (n=3, *p<0.05, **p<0.01, error bars represent  SEM).   
 
The one-way ANOVA showed that in crosslinked 3DENS, NHDF cell viability was 
significantly higher in F10 UCL than F30 UCL (p = 0.02) (Figure 28). Uncrosslinked 
3DENS F20, F30, and F50 had cell viability between 58 %- 70 %.  At 48 hours, cell 
viability increased for all 3DENS with F50 showing the highest viability (94 %), followed 
by F10 (85 %), F30 (82 %) and F20 having the lowest at 62 %. Cell viability at 48 hours 
were not significantly different for any 3DENS formulation (p=0.14). By 72 hours, F10 
UCL showed significantly lower cell viability compared to all other 3DENS and the control 





Figure 28. Viability of NHDF cells on crosslinked 3DENS  
The graphs represent NHDF cell viability on crosslinked 3DENS as a percentage at 24h (A), 48h 
(B) and 72h (C) (n=3, *p < 0.05,**p < 0.01, error bars represent  SEM).   
 
 
Cell viability of NHDF on the various crosslinked 3DENS scaffolds were less than 70 % 
which are generally not considered viable however, the one-way ANOVA showed no 
significant differences between the different formulations at 24 hours (p = 0.23) (Figure 
29). At 48 hours, cell viability gradually decreased from F10 CL to F50 CL. F10 CL 
showed significantly higher cell viability than F30 CL and F50 CL (p = 0.005). By 72 






Figure 29. Viability of NHDF cells on uncrosslinked and crosslinked 3DENS  
The graphs compare NHDF cell viability on uncrosslinked and crosslinked 3DENS as a percentage 
at 24h (A), 48h (B) and 72h (C) (n=3, *p < 0.05, **p < 0.01,***p < 0.001, error bars represent  
SEM).     
 
The cell viability of NHDF of uncrosslinked 3DENS and crosslinked 3DENS was 
compared using a T-test (Figure 30). At 24 hours, F10 UCL performed significantly better 
than F10 CL (p = 0.04), and there were no significant differences between the 
uncrosslinked and crosslinked 3DENS for F20, F30 and F50 (p > 0.05). At 48 hours, 
uncrosslinked 3DENS F30 and F50 performed significantly better than the crosslinked 
formulation (p = 0.02 and p = 0.002, respectively). At 72 hours, uncrosslinked 3DENS F20, 







4.9.3 Cell Proliferation using HaCaT Cell Line 
The proliferation of HaCaT cells were measured on uncrosslinked and crosslinked 3DENS 
at 24h, 48, and 72h. The number of cells present in each 3DENS at various time points are 




Figure 30. Proliferation of HaCaT cells on uncrosslinked 3DENS  
The graphs represent the number of HaCaT cells on uncrosslinked 3DENS at 24h (A), 48h (B) and 
72h (C) (n=6, *p < 0.05, error bars represent  SEM).  
 
At 24 hours, the proliferation rate of HaCaT cells increased as the percentage of chitosan in 
the uncrosslinked 3DENS formulations increased from F10 to F50 (Figure 31). These 
differences were not significant (p = 0.19). At 48 hours, UCL F50 performed significantly 
better than UCL F10 (p = 0.03). By 72 hours, the proliferation rate dropped for 3DENS F20 
to F50 while F10 maintained its proliferation and had the highest cell count. However, no 
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Figure 31. Proliferation of HaCaT cells on crosslinked 3DENS  
The graphs represent the number of HaCaT cells on crosslinked 3DENS at 24h (A), 48h (B) and 72h 




In the crosslinked 3DENS, no significant difference was found in the proliferation rate of 
HaCaT cells at 24 hours (p = 0.37) (Figure 32). At 48 hours, F10 CL had significantly 
lower proliferation rate than all other formulations and the control (p = 0.004). By 72 hours, 







Figure 32. Proliferation of HaCaT cells on uncrosslinked and crosslinked 3DENS  
The graphs compare the number of HaCaT cells on uncrosslinked and crosslinked 3DENS at 24h 
(A), 48h (B) and 72h (C) (n=3, error bars represent  SEM).  
 
A t-test was used to compare the proliferation of HaCaT cells in uncrosslinked and 
crosslinked scaffold for each formulation at 24, 48 and 72 hours. At 24 hours (Figure 33). 
the crosslinked 3DENS appeared to perform better than uncrosslinked 3DENS, however 
this difference was not significant (p > 0.05). There were no significant differences between 
the proliferation rate of HaCaT cells in the uncrosslinked and crosslinked 3DENS at 48 and 




4.9.4 Cell proliferation using the NHDF cell line 
The proliferation of NHDF cells were measured on uncrosslinked and crosslinked 3DENS 
at 24h, 48, and 72h. The number of cells present in each 3DENS at various time points are 
presented in the graphs shown in Figures 34-36.  
 
 
Figure 33. Proliferation of NHDF cells on uncrosslinked 3DENS  
The graphs represent the number of NHDF cells on uncrosslinked 3DENS at 24h (A), 48h (B) and 
72h (C) (n=6, *p < 0.05, p < 0.01, error bars represent  SEM).  
 
The number of proliferative cells on the 3DENS at 24 hours increased from F10 UCL to 
F50 UCL but no significant differences were seen (p = 0.13) (Figure 34). At 48 hours, F30 
UCL had the highest rate of proliferation and it was significantly higher than F10 UCL and 
the control (p = 0.01). By 72 hours, there were no significant difference in the proliferation 




Figure 34. Proliferation of NHDF cells on crosslinked 3DENS  
The graphs represent the number of NHDF cells on crosslinked 3DENS at 24h (A), 48h (B) and 72h 




The proliferation assay of NHDF cells on crosslinked 3DENS showed no differences 
between the different formulations at 24 and 48 hours (p = 0.44 and p = 0.32, respectively) 
(Figure 35). At 72 hours, the number of proliferative cells seemed to increase from F10 CL 
to F50 CL however, this increase was not significant (p = 0.23). At 72 hours, the number of 
NHDF cells on F20 CL, F30 CL and F50 CL 3DENS were higher than the control group 





Figure 35. Proliferation of NHDF cells on uncrosslinked and crosslinked 3DENS  
The graphs compare the number of NHDF cells on uncrosslinked and crosslinked 3DENS at 24h 
(A), 48h (B) and 72h (C) (n=3, error bars represent  SEM).  
 
 
T-tests were used to compare the proliferation of NHDF cells on uncrosslinked 3DENS 
compared to crosslinked 3DENS. There were no significant differences between them for 
any formulation at 24 hours (p > 0.05) (Figure 36). At 48 hours, uncrosslinked F20 and F30 
had higher cell numbers than crosslinked F20 and F30, however, these differences were not 
significant (p > 0.05). By 72 hours, the number of proliferative NHDF cells were higher in 
crosslinked 3DENS than uncrosslinked 3DENS, however the differences were not 




4.9.5 Summary of Biological Analysis 
The findings of the biological assays are summarised as follows: 
• HaCaT and NHDF cells were viable in all uncrosslinked and crosslinked 3DENS. 
UCL 3DENS performed significantly better than CL 3DENS.  
• At 48 hours, HaCaT cell proliferation was significantly higher in CL and UCL 
3DENS with a higher amount of chitosan, however, by 72 hours, there were no 
differences between the formulations.  
• F30 UCL had the highest number of proliferative NHDF cells at 48 hours, however, 
at 72 hours, the UCL 3DENS were not different from each other. CL 3DENS 






At present, there are no studies using thermal crosslinking without any added chemical 
crosslinking agents to crosslink chitosan-based scaffolds. While chitosan, PVA and PVP 
blend 3DENS have been fabricated and characterised physically, no biological 
characterisations have been done for this combination for the application of dermal tissue 
regeneration. In the present study, the overarching aim was to use electrospinning 
technology to fabricate a 3DENS using combination of chitosan, PVA and PVP, and to 
assess its suitability as a dermal tissue regenerative scaffold in vitro. To achieve this aim, 
the spinning solutions where physically characterised, electrospinning parameters were 
optimised, the 3DENS were characterised physically and chemically, and the in vitro 
biological compatibility of the scaffolds were assessed. The main results of the study are as 
follows:  
1. The pH of the blend solutions gradually decreased with the increase in the amount 
of chitosan.  
2. The addition of 2 % chitosan decreased the electrical conductivity of the blend 
solutions.  
3. The decrease in viscosity of the blend solutions was attributed to the decrease in the 
amount of PVA in the solution as the proportion chitosan increased.  
4. Blend formulations of chitosan, PVA and PVP displayed shear thinning behaviour. 
PVA behaved as a structured fluid. 
5. The voltage required to produce a Taylor cone with a continuous jet increased as the 
amount of chitosan in the formulation increased. 
6. The average fibre diameter decreased from 0.22 m to 0.05 m from F10 to F50.  
7. 3DENS degraded faster as the amount of chitosan increased.  
8. Crosslinked 3DENS displayed higher water adsorption capacity than uncrosslinked 
3DENS.  
9. Both HaCaT and NHDF cells showed good viability in all uncrosslinked and 
crosslinked 3DENS. UCL 3DENS performed significantly better than CL 3DENS in 
terms of NHDF viability.  
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10. Cell proliferation of both HaCaT and NHDF cell lines on uncrosslinked and 
crosslinked scaffolds were similar regardless of formulation and were comparable to 
the control groups at various time points. 
5.1 3DENS Fabrication Parameters and Fibre Morphology 
Electrospinning technique was used as it creates a scaffold that mimics ECM architecture. 
Fresh 3DENS scaffolds were prepared in the lab for experiments throughout the duration of 
the study. The same electrospinning parameters were used successfully to spin new 3DENS 
each time. However, if the 3DENS was to be made in a different lab in a different region or 
country, environmental factors such as temperature and humidity should be taken into 
account as these have a direct influence on the electrospinning parameters.  
Chitosan was chosen due to its structural similarity to GAG which is a key component of 
the ECM as previously discussed (section 1.1). 3DENS were successfully produced using 
chitosan, PVA and PVP; confirmed by the presence of IR peaks characterises of the raw 
materials in the 3DENS in FTIR graphs. A polymer concentration should be high enough, 
but not above the critical value that could induce blockage, to generate molecular chain 
entanglements needed to prevent the breaking up of the polymer jets and allow electrostatic 
stresses to elongate them (Taylor 1969). Therefore, PVP was kept a constant concentration 
of 10% to ensure the solution had the necessary viscosity to be electrospun independent of 
chitosan and PVA concentrations. Despite these efforts, not all formulations produced 
fibres. Successful concentration of chitosan solution in the blend formulations that could be 
electrospun were <70 % (<32 % dry weight of chitosan). The successful fabrication of 
fibres for formulations F10, F20, F30 and F50 suggests that they had chain entanglements 
greater than 2.5 entanglements per chain (Shenoy et al. 2005). Unlike in the present work, 
previous studies successfully electrospun polymer solutions containing dry weight ratio of 
chitosan greater than 32%. This disparity could be due to the higher concentration of 
chitosan solution used in these studies. In the present study, the total solute concentration 
decreased as the proportion of chitosan increased. This means that the number of chain 
entanglements also decreased as the chitosan component of each electrospinning solution 
increased where F70 had chain entanglements less than 2.5 entanglements per chain and 
was unable to produce a fibre. The parameters used for the generation of the 3DENS were a 
10 ml syringe supplying polymer solution at a flow rate of 0.3 ml/h to a needle (0.51 mm 
inner diameter) connected to a positive electrode placed 15 cm away from a cylindrical 
collector; which was wrapped in aluminium foil connected to a negative electrode for the 
collection of nanofibers under varying amounts of voltage (between 15 kV and 20 kV). A 
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distance of 15 cm was used by all of the three studies that spun solutions containing 
chitosan, PVA and PVP (Aytimur and Uslu 2014, Gökmeşe, Uslu, and Aytimur 2013, 
Zhang et al. 2014). Table 9 provides a summary of the polymers, parameters, 




Table 9. Summary of previous work fabricating 3DENS using Chitosan, PVA and PVP 
Polymer Dry Weight Composition 
Ratio 
Parameters Tests Application Reference 
10 % Chitosan  
(Mw: 400 kDa) 
10 % PVA  
(Mw: 85k Da-146 kDa)  
10 % PVP K-30  






Needle size: n.s. 
Flow Rate: 0.5 ml/h 
Voltage: 20 kV 







Wound dressing (Gökmeşe, 
Uslu, and 
Aytimur 2013) 
10 % Chitosan  
(400 kDa) 
10% PVA  
(Mw: 85 kDa-124 kDa) 
10 % PVP K30  




Needle size: n.s. 
Flow Rate: 0.5 ml/h 
Voltage: 15-20 kV 








10 % Chitosan 
10 % PVA 
10 % PVP 





Needle size: 0.47 
mm 
Flow Rate: n.s. 
Voltage: 9.5 kV 








(Zhang et al.) 
 




The minimum voltage needed to produce a continuous jet was used to spin each 
formulation followed by a higher voltage to compare the nanofiber structures produced 
using SEM micrographs. Gökmese et al., and Aytimur et al. showed SEM micrographs with 
similar fibre morphology of chitosan, PVA and PVP fibres that were similar to those 
demonstrated here (Aytimur and Uslu 2014, Gökmeşe, Uslu, and Aytimur 2013). The 
voltage required to produce a Taylor cone and continuous polymer jet increased as the 
proportion of chitosan in the solution increased. The polymer jet became more unstable as 
formulations with higher chitosan were spun. The voltage range used to produce the final 
3DENS in this study was 15 kV for F10 which had the lowest amount of chitosan and 
increasing up to 20 kV for F50 which had the highest amount of chitosan. This range is 
consistent with voltage used in two of the previous work, however, the flow rate used in 
these studies were higher than the current study (0.5 ml/h and 0.3 ml/h) (Aytimur and Uslu 
2014, Gökmeşe, Uslu, and Aytimur 2013). The molecular weight (Mw) of chitosan used in 
previously done studies was half the Mw of chitosan used in the present study (400 kDa and 
800 kDa, respectively), so it would be expected that they would require a lower voltage to 
spin the solution. However, Gökmeşe and others used more than twice the concentration of 
chitosan than the current study (2013). On the other hand, Aytimur and others used 20 % 
dry weight concentration of chitosan which was comparable to F50 which had 17 % 
chitosan in dry weight but still used 15 kV-20 kV to produce a fibre despite having a lower 
molecular weight of chitosan (2014). Zhang and others used a voltage of 9.5 kV to produce 
fibres but did not provide information on the molecular weight of the polymers or the flow 
rate that was used (2014).  
Chitosan had the lowest pH and highest conductivity from the three polymer solutions. Its 
proportional increase in the blend formulations caused an overall decrease in pH and 
increase in conductivity. In terms of conductivity, chitosan was 7 times more conductive 
than PVA and 34 times more conductive than PVP. Therefore, it is no surprise that the 
addition of chitosan had the greatest influence on increasing the conductivity of the blend 
formulations as a result of the protonation of –NH2 groups of chitosan in acetic acid 
aqueous solution (Çay, Miraftab, and Perrin Akçakoca Kumbasar 2014). F70 which was 
made up of 70 % chitosan solution had a similar pH to pure chitosan solution (3.96 and 
3.88, respectively) and the same conductivity (3962 S/cm). Its similarity to pure chitosan 
may be the reason for the lack of success in spinning this formulation which resulted in 
spraying in a powder form instead of collection of well-formed fibres.  
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The influence of conductivity on the morphology of the nanofibers are consistent with the 
literature which states that an increase in conductivity decreases fibre diameter 
(Ramakrishna et al. 2006). Thinner fibres are a result of an increased electrical force 
enhancing electrostatic repulsive force on the polymer jet (Aytimur and Uslu 2014). Similar 
to pure chitosan, the very high conductivity of F70 likely caused a negative effect on the 
Taylor cone and resulting in electro-spraying instead of polymer solution instead of fibres 
formation as seen in the SEM images in Figure 13 (Haider, Haider, and Kang 2018). A 
voltage of 23 kV was required to form a Taylor cone at a flow rate of 0.3 ml/h. Flow rate 
higher than 0.3 ml/h will demand a voltage higher than 23 kV in order to produce Taylor 
cone and polymer jet. 
Polymer solutions contain molecules and particles; when put into motion, they are forced to 
slide along each other. The flow resistance caused by this internal friction is viscosity 
(Mezger 2006). In general, chitosan is very viscous and at 5 %- 10 % solution 
concentrations of chitosan, its addition to PVA/PVP blend would have increased the 
solution viscosity (Aytimur and Uslu 2014). However, because only a 2 % chitosan solution 
was use, when the proportion of chitosan solution increased in the formulation, the total 
solute concentration decreased as seen in Table 3 leading to a decrease in the viscosity of 
the blend formulations from F10 to F70. All the samples in this study displayed shear 
thinning behaviour, therefore its viscosity was reported at specific shear rate (200/s).  
In higher viscosity spinning solutions, a higher number of chain-entanglements are present 
making it easier to produce a stable jet and obtain better fibres as seen for F10, which had 
the highest viscosity (Zhang et al. 2014). Haider et.al also stated that a decrease in viscosity 
leads to bead formation; this was observed in the SEM micrographs from the present study 
(Figure 13) (Haider, Haider, and Kang 2018). Smooth fibres were obtained for F10 which 
had the highest viscosity, and a higher number of beads were found in F20, F30 and F50.  
The beads initially seen in F10 electrospun at 13 kV were removed when F10 was 
electrospun at 15 kV. Since all other parameters were maintained, the removal of beads can 
be attribute to the increase in voltage. Using voltages higher than 15 kV may produce fibres 
with smaller diameter (Sill and von Recum 2008).  When voltage was increased from 15 kV 
to 18 kV at the same flowrate for F30, the beads became more circular indicating that the 
higher voltage caused more stretching resulting in thinner fibres. The formation of beaded 
fibres seen formulations F20 to F50 could also be attributed to the increase of repulsive 
forces between ionic groups (Çay, Miraftab, and Perrin Akçakoca Kumbasar 2014). 
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Overall, fibre diameter decreased from F10 to F50 which is consistent with the literature 
which states that fibre diameter decreases as the viscosity of the polymer solution decreases 
and as conductivity increases (Haider, Haider, and Kang 2018, Ramakrishna et al. 2006).  
Analysis of fibre diameter showed that F10 produced thicker and linear fibres than all the 
other formulations. This finding is in line with the expected theoretical correlation between 
strong mechanical properties and structural integrity and is further supported by the 
frequency sweep data. The graphs showed that PVA displayed more elastic properties 
(Figure 12, B). This explains why F10, which had the highest PVA component, was able to 
form uniform fibres. The formulations with higher PVA component resisted deformation 
during the ES process and resulted in smoother fibres owing to PVA’s structural integrity. 
It should be noted that these measurements are true for a temperature around 20C. It has 
been shown that G’ dependence on ω changes with temperature while G” remains 
unaffected. PVA displays more viscous properties than elastic (G” > G’) at higher 
temperatures (Bercea et al. 2020). This would be an important consideration of the 
fabrication of the 3DENS were to take place in hotter climates as electrospinning 
parameters would be affected if the viscoelastic properties of the polymer solutions change.  
Formulation F10 which had the highest component of PVA, showed G’ very close to G”, 
hence it was able to store energy under deformation and create solid fibres as seen in the 
SEM analysis. As the component of PVA decreased from F10 to F70, G’ and G” shifted 
further apart indicating that the viscous properties becoming more dominant. 
5.2 Crosslinking of 3DENS 
A thorough literature search yielded no results on crosslinking of chitosan, PVA or PVP 
using only heat without any added chemical crosslinkers. Our study thermally induced 
physical crosslinking in the 3DENS by applying heat at 120C for 24 hours to increase the 
mechanical strength of our scaffolds, thus removing the need for toxic chemicals.  
There were no clear differences observed in the FTIR peaks between the crosslinked and 
uncrosslinked 3DENS. One possible reason for this is that PVA and PVP peaks could be 
masking other peaks because the amount of chitosan used was minimal. However, the 
successful crosslinking of the 3DENS is evident from the degradation and swelling results 
seen in the study.  
Our experiment exhibited the same colour change as Schiffman observed, which is, the 
mats changed colour from white (when spun) to yellow after crosslinking (Schiffman and 
Schauer 2007). Moreover, as the amount of chitosan in the 3DENS increased, the yellow 
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colour also became more saturated. The successful crosslinking of 3DENS are clearly 
supported by the swelling and degradation data. Crosslinked 3DENS degraded slower than 
uncrosslinked 3DENS due to having higher mechanical strength. As expected, a faster 
degradation rate was observed in 3DENS as the amount of chitosan in the formulation 
increased. Chitosan degrades much faster in physiological environment compared to PVA 
and PVP (Mahoney et al. 2012). The higher synthetic polymer concentration in lower 
chitosan containing 3DENS, contributes to their stronger mechanical properties and 
resistance to degradation. Schiffman et al, studied the degradation of uncrosslinked 
compared to crosslinked chitosan electrospun mats in acidic, neutral and basic environment 
and found that crosslinked scaffolds were able to resist degradation. The crosslinked 
chitosan scaffold survived all three environments where as the uncrosslinked scaffold only 
survived in basic environment (Schiffman and Schauer 2007).   
Liu and others measured the degradation rate of crosslinked chitosan/gelatin  and 
chitosan/gelatin/HA scaffolds and found a degradation rate of 46 % and 55 % at 14 days, 
respectively (Liu 2007). The scaffold in the previous study contained 20 % chitosan in dry 
weight ratio. The crosslinked 3DENS F50 in the current study is comparable to that (17 %) 
chitosan and showed a similar degradation rate of 42 % at day 14. 
The commercially available Integra™ Matrix Wound Dressing (Integra Life Sciences) graft 
matrix degrades in 2-3 weeks leaving behind the silicone covering which can then be 
removed (Turner 2015). Crosslinking the membrane preserved the matrix’s resistance to 
biodegradation and increased tensile strength. A similar outcome was observed in the 
present study. The crosslinked 3DENS fabricated in the present study displayed slower 
biodegradation compared to the uncrosslinked 3DENS and it was also easier to handle and 
did not break as easily. The rate of degradation for the 3DENS fabricated in the present 
study was 40%-60% at two weeks. However, the degradation rate of the 3DENS rate could 
be increased by manipulating polymers concentrations and testing different electrospinning 
parameters.  
In this study, crosslinking was successfully used to preserve the matrix’s resistance to 
biodegradation and increase tensile strength. The higher tensile strength means that the 
handling of the 3DENS would be easier for use in clinical settings. Moreover, in-vitro 
biological analysis using dermal tissue cell lines showed promising results for its use in 




Swelling data was unobtainable for 3DENS with chitosan percentages greater than 30%, 
due to their delicate nature. F30 crosslinked was measurable but not F30 uncrosslinked 
given its weaker structural integrity compared to the crosslinked scaffold. Findings of the 
swelling study attests to the success of the crosslinking method used. Swelling data showed 
significantly higher water adsorption capability in crosslinked F30 compared to lower 
chitosan containing formulations. This finding is consistent with the literature that states 
that an increase in water adsorption capacity can be expected with increasing amounts of 
chitosan due to the presence of hydroxyl groups and amino groups of the chitosan which 
have strong affinity towards water (Smitha, Sridhar, and Khan 2004). Crosslinked 3DENS’s 
were able to hold a significantly larger amount of water within its structure. The higher 
water adsorption capacity seen in crosslinked 3DENS compared to uncrosslinked 3DENS 
could be attributed to a higher number of functional hydrophilic groups created by 
crosslinking. This provides further evidence that the crosslinking method used was 
successful in crosslinking the 3DENS thereby creating a mechanically stronger scaffold. 
Moreover, the scaffolds in the present study showed higher swelling ratios than Çay et al. 
(2014). The increase in swelling ratio could be attributed to the lower heating temperature 
used being less damaging to the structure (Çay, Miraftab, and Perrin Akçakoca Kumbasar 
2014). It is well known that wet environments are more suitable for wound healing. 
Crosslinked 3DENS fabricated in this study could provide the architecture and wet 




5.3 Analysis of Biological Compatibility of the 3DENS 
The nano-dimensional porous structure created by the electrospinning technique resembles 
the native ECM of skin tissue. The porous nature of the scaffold should also encourage cell 
migration and provide cells with an increased number of sites for attachment and 
proliferation. The 3DENS fabricated in the current study displayed good structural integrity 
and mechanical properties.  Therefore, they may be considered suitable as a substitute for 
skin tissue regeneration. In order to adequately represent human skin, fibroblasts and 
keratinocyte cell types were chosen to assess the biological activity of the 3DENS as they 
are the predominant cell types found in the dermis and epidermis, respectively. The HaCaT 
cell line was used in the study as it can be used for extended periods of time compared to 
primary cell lines.  Dermal fibroblasts are available as the primary cell line NHDF (normal 
human dermal fibroblasts). HaCaT and NHDF were used as they were quick to culture and 
readily available. To our knowledge, chitosan/PVA/PVP 3DENS have not been studied in 
vitro for dermal tissue regeneration. 
HaCaT and NHDF cell lines were both used perform the in vitro assays. The same 
experimental and environmental conditions were used with both cell lines. Three separate 
flasks for each of the cell lines were used to maintain n=3. Each test, MTT and Live/Dead 
cell assay, was reproduced three times using three different samples (n=3). Within each of 
those groups, the experiment was replicated and the results averaged to maintain triplicate.  
The most important fact to note that based upon observations, both HaCaT and NHDF cells 
penetrated deeper layers of the 3DENS’s. The gold standard of all scaffolds is that they 
have the ability to attract the cells and the cells are able to penetrate the structure and 
remain viable and proliferative. Both cell types were seen at different focal planes under the 
microscope indicating that they penetrated the scaffold. 
Overall, HaCaT cells showed viability around 80% on all uncrosslinked 3DENS, above the 
70% which is considered to be an acceptable criterion for viable proliferation.  The viability 
levels remained at or higher than the controls of cells alone. The crosslinked scaffolds 
showed low HaCaT cell viability on F10 and F20 (<70 %) and good viability for F30 and 
F50 (>70 %) at 24 hours. The difference in viability between the crosslinked formulations 
were not significant at any time point. However, F10 CL was markedly lower than the 
control group at 72 hours. When comparing crosslinked to uncrosslinked 3DENS for the 
same formulations. There were no significant differences in performance between 
uncrosslinked and crosslinked 3DENS in terms of HaCaT cell viability. The results were 
very similar to the uncrosslinked and crosslinked control groups.  
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In terms of proliferation, HaCaT cells showed higher proliferation with increasing amounts 
of chitosan in uncrosslinked 3DENS (F10 to F50) at 24 and 48 hours. F20 UCL to F50 
UCL were higher than the control group. However, at 72 hours, the opposite was observed. 
F10 had the lowest proliferation rate at 48 hours, maintained its number of cells and was the 
highest rate at 72 hours. The number of HaCaT cells decreased as the amount of chitosan in 
uncrosslinked 3DENS increased at 72 hours. In the crosslinked samples, there were no 
significant differences between any of the crosslinked 3DENS at any time point. At 72 
hours, F20, F30 and F50 appeared to perform better than F10 but all values remained 
around the cell numbers in the control group. 
For NHDF cell viability on uncrosslinked scaffolds, at 72 hours, F20 UCL, F30 UCL, and 
F50 UCL all showed good cell viability (>70 %).  In the crosslinked 3DENS, F10 CL 
initially showed low cell viability however, it was significantly higher than other 3DENS at 
72 hours. In terms of overall cell viability when comparing uncrosslinked 3DENS to 
crosslinked 3DENS, the uncrosslinked scaffolds showed significantly higher NHDF cell 
viability; where formulations F20, F30 and F50 showed the best NHDF cell viability at 72 
hours. Due to its positive charges, chitosan is a bio-adhesive (He, Davis, and Illum 1998). 
This could attribute to the higher number of viable cells counted in the uncrosslinked 
scaffolds which had more chitosan available to interact with NHDF cells.  
The proliferation of NHDF on uncrosslinked 3DENS initially showed no significant 
differences between the 3DENS at 24 and 72 hours. At 48 hours, F30 UCL had a 
significantly higher cell count, however, by 72 hours, it appeared to have the lowest. In 
crosslinked scaffolds, NHDF proliferation was low for all 3DENS but gradually increased 
by 72 hours. There were no significant differences between the 3DENS although the 
number of cells increased on crosslinked 3DENS as the amount of chitosan increased.  
When comparing the proliferation of NHDF on uncrosslinked 3DENS compared to 
crosslinked 3DENS, the crosslinked 3DENS reported much higher cell counts than 
uncrosslinked. However, this finding was not significant.  
Abdull Rasad and others performed cell viability assay using NHDF cells on chitosan/PVP 
sheets and found that chitosan containing sheets (3-5% chitosan) showed significantly 
higher cell viability compared to the control at 24 hours. They also saw a higher cell 
viability at 48 and 72 hours, however this was not significantly different to the control 
(Abdull Rasad 2010).Although it was not significant, a similar trend was seen in the current 
study; uncrosslinked 3DENS with chitosan in the range of 2-5% showed higher cell 
viability at 24, 48 and 72 hours compared to control. 
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The author was unable to find in-vitro studies for the commercially available Integra™ 
Matrix Wound Dressing (Integra Life Sciences). It could be possible that since the product 
was studied in the 1980’s, that such a study does not exist. Results of in-vitro analysis 
performed on the 3DENS fabricated in the current study using two dermal cell lines 
strongly suggests that the environment is suitable for supporting dermal tissue regeneration.  
The overall finding of this cytotoxicity study seemed to be that all formulations proliferated 
at a similar rate and had a similar viability to the cells only control. The cells whether in the 
presence of the crosslinked or uncrosslinked scaffold remained at similar levels. The cells 
penetrated through the scaffold indicating that the 3DENS environment was favourable for 
cell viability and growth. Crosslinked chitosan/PVA/PVP 3DENS could potentially serve as 
a template for the construction of a synthesised “neodermis” by slowly biodegrading and 
being reabsorbed by the body over several months. 
 
5.4 Conclusion 
A three dimensional nanofibrous scaffold (3DENS) using a combination of chitosan, PVA 
and PVP using electrospinning was fabricated. The method used to thermally induce 
physical crosslinking in the 3DENS was successful and improved the hydrophilicity and 
mechanical properties of the 3DENS. The crosslinked scaffolds exhibit similar biological 
properties compared to the uncrosslinked scaffolds and the control group. The cells 
successfully penetrated into deeper layers in the 3D scaffold. 
The electrospinning technique was used in this project due to its ability to produce porous 
scaffolds in the nano-dimension. Moreover, electrospinning is relatively cheap compared to 
other nano-fabrication technology and is able to mass produce scaffolds. Cost-effectiveness 
is an important consideration for the clinical translation of the product to low- and middle-
income countries where resources are limited. Chitosan was selected for its biological 
advantages. Chitosan comes from the crustacean shell which a renewable resource and adds 
value to waste material. However, it is difficult to electrospin chitosan on its own and 
carrier polymers, PVA and PVP, were used in order to make spinning easier.  
The proportion of chitosan in the electrospinning solution had the greatest effect on the pH 
and conductivity of the solutions. Rheological studies of the polymer solutions revealed that 
PVA behaved as a structured solid therefore, had the greatest influence on the viscosity of 
the solution. All blend formulations behaved like shear-thinning fluids. The voltage 
required to produce a Taylor cone with a continuous jet increased as the amount of chitosan 
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in the formulation increased. All 3DENS fibres were in the submicron size ranging with the 
average fibre diameter decreasing from 0.22 m to 0.05 m, from formulations F10 to F50. 
The addition of chitosan to 3DENS increased the rate of degradation in the scaffolds. Heat 
was successfully used to crosslink the 3DENS’s. Thermally crosslinking chitosan, PVA and 
PVP 3DENS resulted in a mechanically stronger yet more hydrophilic scaffolds which is an 
advantage for wound healing applications. Moreover, all chitosan containing 3DENS 
scaffolds displayed good cell attachment, viability and proliferation. Chitosan containing 
skin tissue scaffolds would be able to increase retention of the scaffold at the wound site 
and its porous nature could encourage cell infiltration to deeper layers of the scaffold, 
enhancing wound healing. 
5.5 Limitations  
The method used to conduct swelling studies is typically the method used by most 
researchers in the field (Gu et al. 2009). However, this study design is not capable of 
measuring the swelling of very delicate 3DENS due to the scaffold breaking into pieces too 
small to handle. The wet 3DENS also have a tendency to stick to the filter paper during the 
blotting step for removing excess water. This can affect the final reading in two ways; it can 
increase the final weight reading due to the wet scaffold picking up fibres from the filter 
paper or it could reduce the final weight reading due to some of the scaffold staying behind 
on the filter paper during removal. Better methods need to be established to overcome the 
handling challenges faced when 3DENS are in wet condition. One possible solution to 
overcome this challenge is by using transwells which have a mesh like structure at the 
bottom of the insert well. This removes the need for handling the 3DENS as it can be 
sieved.  
The 3DENS in the current study were difficult to peel from the aluminium foil. One reason 
for this could be that the 3DENS produced in this study were very light. For removal, the 
3DENS was wet first with PBS after which it could be peeled off the aluminium foil easily. 
As the amount of chitosan increased, the 3DENS became more difficult to handle in wet 
condition. This is also evident from the images of the 3DENS submerged in PBS in day 7 
swelling images. One way to overcome this challenge is to produce thicker scaffolds. 
5.6 Future Direction 
The results from this study can contribute substantially to the field of dermal tissue 
engineering and in particular, to encourage the use of physical crosslinking method to 
stabilise chitosan containing scaffolds instead of using chemical crosslinkers.  
 
97 
The intrinsic antimicrobial strength of chitosan before and after crosslinking need to be 
investigate using microbiological techniques. Furthermore, longer term degradation needs 
to be conducted to determine the kinetic degradation profile of the 3DENS from one 
hundred percent to fully degraded to be able to manipulate formulations and crosslinking 
strength in order to obtain desired degradation time.  
The porous nature of the scaffolds in the current study encouraged cell infiltration into 
deeper layers. The manipulation of electrospinning parameters to obtain fibres of different 
morphology (e.g. fibre diameter, pore size, surface texture) for each formulation in order to 
investigate the cell attachment and proliferation should be investigated. It has also been 
stated in the literature that interconnected pores result in better angiogenesis. Angiogenesis 
should be investigated using immunohistological methods.  
Crosslinked 3DENS showed excellent water retention capacity which is desirable as it now 
a well-known fact that moist environments result in better wound healing outcomes. The 
current study established the suitability of chitosan/PVA/PVP 3DENS for cell viability and 
growth. However, these results need to be further supported by studies in established burn 
wound models and with animal studies to determine clinical translation opportunities. In-
vivo experiments should also be carried out to investigate effects of 3DENS on growth 
factor production and cell signals. 
While the use of chitosan in wound dressing has been approved by the FDA, it has not yet 
been approved for drug delivery, despite the numerous amounts of studies showing the 
positive benefits of chitosan containing scaffolds (Kean and Thanou 2010). Due to this, 
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